ORIGINAL_ARTICLE
A World of Changes: The Inheritance of COVID-19
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the viral agent of coronavirus disease 2019 (COVID-19), expanded its territory to almost all the globe very soon after its first diagnosis in Dec. 2019 in Wuhan, China.1 Hardly a single aspect of life could be found that is not affected by COVID-19 outbreak. During about four months, the pandemic has introduced substantial challenges besides the health crisis, including severe restrictions in common daily habits as well as an immense impact on economy, financial losses, and lockdown of some industries, to name a few.
https://ijms.sums.ac.ir/article_46530_2086bb7b445b312e9b60c9f60fef9f23.pdf
2020-05-01
155
156
10.30476/ijms.2020.46530
Covid
19
Manica
Negahdaripour
monica.negahdaripour@gmail.com
1
Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
LEAD_AUTHOR
Negahdaripour M. The Battle Against COVID-19: Where Do We Stand Now? Iran J Med Sci. 2020;45:81-2. doi: 10.30476/ijms.2020.46357. PubMed PMID: 32210483; PubMed Central PMCID: PMCPMC7071545.
1
Harrison C. Coronavirus puts drug repurposing on the fast track. Nat Biotechnol. 2020;38:379-81. doi: 10.1038/d41587-020-00003-1. PubMed PMID: 32205870.
2
Vogel G. Antibody surveys suggesting vast undercount of coronavirus infections may be unreliable. Science. 2020;4. doi: 10.1126/science.abc3831.
3
Dutheil F, Baker JS, Navel V. COVID-19 as a factor influencing air pollution? Environ Pollut. 2020;263:114466. doi: 10.1016/j.envpol.2020.114466. PubMed PMID: 32283458; PubMed Central PMCID: PMCPMC7144597.
4
Tabari P, Amini M, Moghadami M, Moosavi M. International Public Health Responses to COVID-19 Outbreak: A Rapid Review. Iranian Journal of Medical Sciences. 2020;45:157-69. doi: 10.30476/IJMS.2020.85810.1537.
5
Wadman M, Couzin-Frankel J., Matacic C. How does coronavirus kill? Clinicians trace a ferocious rampage through the body, from brain to toes. Science. 2020;4. doi:10.1126/science.abc3208.
6
ORIGINAL_ARTICLE
International Public Health Responses to COVID-19 Outbreak: A Rapid Review
Background: The outbreak of Coronavirus disease 2019 (COVID-19) has posed a significant threat to many countries. Since the disease does not currently have a particular treatment, there is a compelling need to find substitute means to dominate its expansion. In this rapid review, we aimed to determine some countries’ public responses to the COVID-19 epidemic.Methods: In this study, academic databases, including MEDLINE, Scopus, and Embase, were investigated. The keywords applied in the search strategy besides the names of each country were: “Public Health,” “Public Response”, “Health Policy”, “COVID-19”, “Novel Coronavirus,” “2019-nCoV”, and “SARS-COV-2”. The countries included China, Italy, Iran, Spain, South Korea, Germany, France, United States, Australia, Canada, Japan, and Singapore.Results: The total number of retrieved articles in MEDLINE, Scopus, and Embase in April 2020 was 594, and after removing 259 duplicate articles, 335 papers were screened by the experts. After this investigation, 50 articles, in addition to 12 webpages, were extensively reviewed for the results section. Public health strategies and responses can be divided into four main areas, including monitoring, public education, crowd controlling, and care facilities.Conclusion: According to the results of the management decisions of some governments on quarantining, social isolation, screening methods, and flight suspensions due to the severity and anonymity of COVID-19, it is highly assured that these strategies would be the most successful approaches to confront the present pandemic. Governments should put in place timely and strict measures to halt the spread and diminish its unintended deadly consequences.
https://ijms.sums.ac.ir/article_46525_f5e85df9512bd5ad85de4ff92b6af154.pdf
2020-05-01
157
169
10.30476/ijms.2020.85810.1537
Novel coronavirus
Public Health
Health Policy
Pandemics
Parinaz
Tabari
papiamentu@gmail.com
1
Clinical Education Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
AUTHOR
Mitra
Amini
mitraamini51@yahoo.com
2
Clinical Education Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
LEAD_AUTHOR
Mohsen
Moghadami
moghadami@sums.ac.ir
3
Non‐Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
AUTHOR
Mahsa
Moosavi
musavi.mahsa@yahoo.com
4
Clinical Education Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
AUTHOR
Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020;76:71-6. doi: 10.1016/j.ijsu.2020.02.034. PubMed PMID: 32112977; PubMed Central PMCID: PMCPMC7105032.
1
Battegay M, Kuehl R, Tschudin-Sutter S, Hirsch HH, Widmer AF, Neher RA. 2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate - a word of caution. Swiss Med Wkly. 2020;150:w20203. doi: 10.4414/smw.2020.20203. PubMed PMID: 32031234.
2
Haider N, Yavlinsky A, Simons D, Osman AY, Ntoumi F, Zumla A, et al. Passengers’ destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America. Epidemiol Infect. 2020;148:e41. doi: 10.1017/S0950268820000424. PubMed PMID: 32100667; PubMed Central PMCID: PMCPMC7058650.
3
Zhang L, Liu Y. Potential interventions for novel coronavirus in China: A systematic review. J Med Virol. 2020;92:479-90. doi: 10.1002/jmv.25707. PubMed PMID: 32052466.
4
NCBI [Internet]. LitCovid. [cited 2020 12 April]. Available from: https://www.ncbi.nlm.nih.gov/research/coronavirus/
5
Team C-NIRS. COVID-19, Australia: Epidemiology Report 6 (Reporting week ending 19:00 AEDT 7 March 2020). Commun Dis Intell (2018). 2020;44. doi: 10.33321/cdi.2020.44.21. PubMed PMID: 32156224.
6
Team C-NIRS. COVID-19, Australia: Epidemiology Report 5 (Reporting week ending 19:00 AEDT 29 February 2020). Commun Dis Intell (2018). 2020;44. doi: 10.33321/cdi.2020.44.20. PubMed PMID: 32126197.
7
Team C-NIRS. COVID-19, Australia: Epidemiology Report 4 (Reporting week ending 19:00 AEDT 22 February 2020). Commun Dis Intell (2018). 2020;44. doi: 10.33321/cdi.2020.44.17. PubMed PMID: 32098616.
8
Team C-NIRS. COVID-19, Australia: Epidemiology Report 3 (Reporting week ending 19:00 AEDT 15 February 2020). Commun Dis Intell (2018). 2020;44. doi: 10.33321/cdi.2020.44.15. PubMed PMID: 32074480.
9
Team C-NIRS. COVID-19, Australia: Epidemiology Report 2 (Reporting week ending 19:00 AEDT 8 February 2020). Commun Dis Intell (2018). 2020;44. doi: 10.33321/cdi.2020.44.14. PubMed PMID: 32050080.
10
Patel A, Jernigan DB, nCo VCDCRT. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:140-6. doi: 10.15585/mmwr.mm6905e1. PubMed PMID: 32027631; PubMed Central PMCID: PMCPMC7004396.
11
Nishiura H, Kobayashi T, Yang Y, Hayashi K, Miyama T, Kinoshita R, et al. The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights. J Clin Med. 2020;9. doi: 10.3390/jcm9020419. PubMed PMID: 32033064; PubMed Central PMCID: PMCPMC7074297.
12
Spina S, Marrazzo F, Migliari M, Stucchi R, Sforza A, Fumagalli R. The response of Milan’s Emergency Medical System to the COVID-19 outbreak in Italy. Lancet. 2020;395:e49-e50. doi: 10.1016/S0140-6736(20)30493-1. PubMed PMID: 32119824; PubMed Central PMCID: PMCPMC7124430.
13
Chen S, Yang J, Yang W, Wang C, Barnighausen T. COVID-19 control in China during mass population movements at New Year. Lancet. 2020;395:764-6. doi: 10.1016/S0140-6736(20)30421-9. PubMed PMID: 32105609.
14
Jernigan DB, Team CC-R. Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:216-9. doi: 10.15585/mmwr.mm6908e1. PubMed PMID: 32106216.
15
Government of Canada [Internet]. Coronavirus disease (COVID-19): Outbreak update. [cited 2020 15 March]. Available from: https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection.html
16
Lee VJ, Chiew CJ, Khong WX. Interrupting transmission of COVID-19: lessons from containment efforts in Singapore. J Travel Med. 2020. doi: 10.1093/jtm/taaa039. PubMed PMID: 32167146; PubMed Central PMCID: PMCPMC7107552.
17
Ghanchi A. Adaptation of the National Plan for the Prevention and Fight Against Pandemic Influenza to the 2020 COVID-19 epidemic in France. Disaster Med Public Health Prep. 2020:1-9. doi: 10.1017/dmp.2020.82. PubMed PMID: 32252845.
18
Sani G, Janiri D, Di Nicola M, Janiri L, Ferretti S, Chieffo D. Mental health during and after the COVID-19 emergency in Italy. Psychiatry Clin Neurosci. 2020. doi: 10.1111/pcn.13004. PubMed PMID: 32248608.
19
Kidd M. Australia’s primary care COVID-19 response. Aust J Gen Pract. 2020;49. doi: 10.31128/AJGP-COVID-02. PubMed PMID: 32241074.
20
Kim S, Kim YJ, Peck KR, Jung E. School Opening Delay Effect on Transmission Dynamics of Coronavirus Disease 2019 in Korea: Based on Mathematical Modeling and Simulation Study. J Korean Med Sci. 2020;35:e143. doi: 10.3346/jkms.2020.35.e143. PubMed PMID: 32242349; PubMed Central PMCID: PMCPMC7131906.
21
Davarpanah AH, Mahdavi A, Sabri A, Langroudi TF, Kahkouee S, Haseli S, et al. Novel Screening and Triage Strategy in Iran During Deadly Coronavirus Disease 2019 (COVID-19) Epidemic: Value of Humanitarian Teleconsultation Service. J Am Coll Radiol. 2020. doi: 10.1016/j.jacr.2020.03.015. PubMed PMID: 32208138; PubMed Central PMCID: PMCPMC7118529.
22
Ohannessian R, Duong TA, Odone A. Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action. JMIR Public Health Surveill. 2020;6:e18810. doi: 10.2196/18810. PubMed PMID: 32238336; PubMed Central PMCID: PMCPMC7124951.
23
Sorbello M, El-Boghdadly K, Di Giacinto I, Cataldo R, Esposito C, Falcetta S, et al. The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice. Anaesthesia. 2020. doi: 10.1111/anae.15049. PubMed PMID: 32221973.
24
Worldometers [Internet]. COVID-19 Coronavirus pandemic. [cited 2020 10 April]. Available from: https://www.worldometers.info/coronavirus/
25
Anzai A, Kobayashi T, Linton NM, Kinoshita R, Hayashi K, Suzuki A, et al. Assessing the Impact of Reduced Travel on Exportation Dynamics of Novel Coronavirus Infection (COVID-19). J Clin Med. 2020;9. doi: 10.3390/jcm9020601. PubMed PMID: 32102279; PubMed Central PMCID: PMCPMC7073579.
26
Chen W, Wang Q, Li YQ, Yu HL, Xia YY, Zhang ML, et al. [Early containment strategies and core measures for prevention and control of novel coronavirus pneumonia in China]. Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54:1-6. doi: 10.3760/cma.j.issn.0253-9624.2020.03.003. PubMed PMID: 32064856.
27
Du Z, Wang L, Cauchemez S, Xu X, Wang X, Cowling BJ, et al. Risk for Transportation of 2019 Novel Coronavirus Disease from Wuhan to Other Cities in China. Emerg Infect Dis. 2020;26. doi: 10.3201/eid2605.200146. PubMed PMID: 32053479.
28
Loeb J. China bans sale of wildlife following coronavirus. Vet Rec. 2020;186:144-5. doi: 10.1136/vr.m495. PubMed PMID: 32029660.
29
Zhang S, Wang Z, Chang R, Wang H, Xu C, Yu X, et al. COVID-19 containment: China provides important lessons for global response. Front Med. 2020. doi: 10.1007/s11684-020-0766-9. PubMed PMID: 32212059.
30
Cyranoski D. What China’s coronavirus response can teach the rest of the world. Nature. 2020;579:479-80. doi: 10.1038/d41586-020-00741-x. PubMed PMID: 32203360.
31
Chen S, Zhang Z, Yang J, Wang J, Zhai X, Barnighausen T, et al. Fangcang shelter hospitals: a novel concept for responding to public health emergencies. Lancet. 2020. doi: 10.1016/S0140-6736(20)30744-3. PubMed PMID: 32247320.
32
Ruan L, Wen M, Zeng Q, Chen C, Huang S, Yang S, et al. New measures for COVID-19 response: a lesson from the Wenzhou experience. Clin Infect Dis. 2020. doi: 10.1093/cid/ciaa386. PubMed PMID: 32246149.
33
Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA. 2020. doi: 10.1001/jama.2020.4031. PubMed PMID: 32167538.
34
Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020. doi: 10.1001/jama.2020.4683. PubMed PMID: 32203977.
35
Carenzo L, Costantini E, Greco M, Barra FL, Rendiniello V, Mainetti M, et al. Hospital surge capacity in a tertiary emergency referral centre during the COVID-19 outbreak in Italy. Anaesthesia. 2020. doi: 10.1111/anae.15072. PubMed PMID: 32246838.
36
Paterlini M. Lockdown in Italy: personal stories of doing science during the COVID-19 quarantine. Nature. 2020. doi: 10.1038/d41586-020-01001-8. PubMed PMID: 32242111.
37
Guzzetta G, Poletti P, Ajelli M, Trentini F, Marziano V, Cereda D, et al. Potential short-term outcome of an uncontrolled COVID-19 epidemic in Lombardy, Italy, February to March 2020. Euro Surveill. 2020;25. doi: 10.2807/1560-7917.ES.2020.25.12.2000293. PubMed PMID: 32234117; PubMed Central PMCID: PMCPMC7118340.
38
Ministry of Health and Medical Education [Internet]. New traffic restrictions. [cited 2020 15 March]. Available from: http://behdasht.gov.ir/index.jsp?siteid=1&fkeyid=&siteid=1&pageid=54782&newsview=200689. Persian.
39
Abdi M. Coronavirus disease 2019 (COVID-19) outbreak in Iran: Actions and problems. Infect Control Hosp Epidemiol. 2020:1-2. doi: 10.1017/ice.2020.86. PubMed PMID: 32192541; PubMed Central PMCID: PMCPMC7137533.
40
Seddighi H. Trust in humanitarian aid from the earthquake 2017 to COVID-19 in Iran: A policy analysis. Disaster Med Public Health Prep. 2020:1-9. doi: 10.1017/dmp.2020.54. PubMed PMID: 32216858.
41
Raeisi A, Tabrizi JS, Gouya MM. IR of Iran National Mobilization against COVID-19 Epidemic. Arch Iran Med. 2020;23:216-9. doi: 10.34172/aim.2020.01. PubMed PMID: 32271593.
42
Moradzadeh R. The challenges and considerations of community-based preparedness at the onset of COVID-19 outbreak in Iran, 2020. Epidemiol Infect. 2020:1-6. doi: 10.1017/S0950268820000783. PubMed PMID: 32242790.
43
Social distancing policies in Iran [Internet]. Government of Iran. [cited 2020 4 April]. Available from: http://www.president.ir/fa/114562. Persian.
44
La Moncloa [Internet]. President of the Government calls for political and public unity to overcome coronavirus emergency. [cited 2020 18 March]. Available from: https://www.lamoncloa.gob.es/lang/en/presidente/news/Paginas/2020/20200318parliament.aspx
45
The Guardian [Internet]. Spain orders non-essential workers stay home for two weeks. [cited 2020 28 March]. Available from: https://www.theguardian.com/world/2020/mar/28/covid-19-may-be-peaking-in-parts-of-spain-says-official
46
Shirato K, Nao N, Katano H, Takayama I, Saito S, Kato F, et al. Development of Genetic Diagnostic Methods for Novel Coronavirus 2019 (nCoV-2019) in Japan. Jpn J Infect Dis. 2020. doi: 10.7883/yoken.JJID.2020.061. PubMed PMID: 32074516.
47
Sawano T, Ozaki A, Rodriguez-Morales AJ, Tanimoto T, Sah R. Limiting spread of COVID-19 from cruise ships - lessons to be learnt from Japan. QJM. 2020. doi: 10.1093/qjmed/hcaa092. PubMed PMID: 32170953; PubMed Central PMCID: PMCPMC7094785.
48
The Guardian [Internet]. Japan declares state of emergency over coronavirus. [cited 2020 7 April]. Available from: https://www.theguardian.com/world/2020/apr/07/japan-shinzo-abe-declares-state-of-emergency-over-coronavirus
49
Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020;25. doi: 10.2807/1560-7917.ES.2020.25.6.2000094. PubMed PMID: 32070465; PubMed Central PMCID: PMCPMC7029452.
50
Konrad R, Eberle U, Dangel A, Treis B, Berger A, Bengs K, et al. Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020. Euro Surveill. 2020;25. doi: 10.2807/1560-7917.ES.2020.25.9.2000173. PubMed PMID: 32156330; PubMed Central PMCID: PMCPMC7068163.
51
Franve 24 [Internet]. Merkel announces strict measures, tells Germans to stay home in virus fight. [cited 2020 17 March]. Available from: https://www.france24.com/en/20200317-merkel-announces-strict-measures-and-tells-germans-to-stay-home-in-virus-fight
52
The Politico [Internet]. Germany expands border controls for EU travelers, minister says. [cited 2020 19 March]. Available from: https://www.politico.eu/article/germany-closing-borders-to-eu-travelers-minister-says/
53
The Politico [Internet]. Germany’s Merkel bans meetings of more than 2 people to slow coronavirus. [cited 2020 22 March]. Available from: https://www.politico.com/news/2020/03/22/germany-merkel-bans-meetings-two-people-142283
54
The Guardian [Internet]. Germany’s devolved logic is helping it win the coronavirus race. [cited 2020 5 April]. Available from: https://www.theguardian.com/world/2020/apr/05/germanys-devolved-logic-is-helping-it-win-the-coronavirus-race
55
Webster P. Canada and COVID-19: learning from SARS. Lancet. 2020;395:936-7. doi: 10.1016/S0140-6736(20)30670-X. PubMed PMID: 32199479.
56
Government of Canada [Internet]. Canada’s COVID-19 Economic Response Plan. [cited 2020 12 April]. Available from: https://www.canada.ca/en/department-finance/economic-response-plan.html
57
Wong J, Goh QY, Tan Z, Lie SA, Tay YC, Ng SY, et al. Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore. Can J Anaesth. 2020. doi: 10.1007/s12630-020-01620-9. PubMed PMID: 32162212; PubMed Central PMCID: PMCPMC7090449.
58
Liew MF, Siow WT, MacLaren G, See KC. Preparing for COVID-19: early experience from an intensive care unit in Singapore. Crit Care. 2020;24:83. doi: 10.1186/s13054-020-2814-x. PubMed PMID: 32151274; PubMed Central PMCID: PMCPMC7063757.
59
Wong JEL, Leo YS, Tan CC. COVID-19 in Singapore-Current Experience: Critical Global Issues That Require Attention and Action. JAMA. 2020. doi: 10.1001/jama.2020.2467. PubMed PMID: 32077901.
60
Singapore Government Agency Website [Internet]. Everything you need to know about Quarantine Orders. [cited 2020 25 March]. Available from: https://www.gov.sg/article/everything-you-need-to-know-about-quarantine-orders
61
Singapore Government Agency Website [Internet]. COVID-19 Resources. [cited 2020 10 April]. Available from: https://www.gov.sg/article/covid-19-resources
62
Covid-19 National Emergency Response Center E, Case Management Team KCfDC, Prevention. Contact Transmission of COVID-19 in South Korea: Novel Investigation Techniques for Tracing Contacts. Osong Public Health Res Perspect. 2020;11:60-3. doi: 10.24171/j.phrp.2020.11.1.09. PubMed PMID: 32149043; PubMed Central PMCID: PMCPMC7045882.
63
Ki M, Task Force for -nCo V. Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea. Epidemiol Health. 2020;42:e2020007. doi: 10.4178/epih.e2020007. PubMed PMID: 32035431.
64
Huh S. How to train the health personnel for protecting themselves from novel coronavirus (COVID-19) infection during their patient or suspected case care. J Educ Eval Health Prof. 2020;17:10. doi: 10.3352/jeehp.2020.17.10. PubMed PMID: 32150796.
65
Her M. How is COVID-19 affecting South Korea? What is our current strategy? Disaster Med Public Health Prep. 2020:1-7. doi: 10.1017/dmp.2020.69. PubMed PMID: 32241325.
66
Moradi H, Vaezi A. Lessons Learned From Korea: Covid-19 Pandemic. Infect Control Hosp Epidemiol. 2020:1-5. doi: 10.1017/ice.2020.104. PubMed PMID: 32241308.
67
Stokes DC. Senior Medical Students in the COVID-19 Response: An Opportunity to Be Proactive. Acad Emerg Med. 2020;27:343-5. doi: 10.1111/acem.13972. PubMed PMID: 32215977.
68
Team C-NIRS. COVID-19, Australia: Epidemiology Report 8 (Reporting period from 19:00 AEDT 14 March to 23:59 AEDT 22 March 2020). Commun Dis Intell (2018). 2020;44. doi: 10.33321/cdi.2020.44.28. PubMed PMID: 32223725.
69
Han Q, Lin Q, Jin S, You L. Coronavirus 2019-nCoV: A brief perspective from the front line. J Infect. 2020;80:373-7. doi: 10.1016/j.jinf.2020.02.010. PubMed PMID: 32109444; PubMed Central PMCID: PMCPMC7102581.
70
Xu C, Luo X, Yu C, Cao S-J. The 2019-nCoV epidemic control strategies and future challenges of building healthy smart cities. Indoor and Built Environment. 2020:1420326X20910408. doi: 10.1177/1420326X20910408.
71
Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020;382:970-1. doi: 10.1056/NEJMc2001468. PubMed PMID: 32003551; PubMed Central PMCID: PMCPMC7120970.
72
Raoofi A, Takian A, Akbari Sari A, Olyaeemanesh A, Haghighi H, Aarabi M. COVID-19 Pandemic and Comparative Health Policy Learning in Iran. Arch Iran Med. 2020;23:220-34. doi: 10.34172/aim.2020.02. PubMed PMID: 32271594.
73
Zandifar A, Badrfam R. Fighting COVID-19 in Iran; Economic Challenges Ahead. Arch Iran Med. 2020;23:284. doi: 10.34172/aim.2020.14. PubMed PMID: 32271606.
74
Lazzerini M, Putoto G. COVID-19 in Italy: momentous decisions and many uncertainties. Lancet Glob Health. 2020. doi: 10.1016/S2214-109X(20)30110-8. PubMed PMID: 32199072; PubMed Central PMCID: PMCPMC7104294.
75
Yuan J, Li M, Lv G, Lu ZK. Monitoring Transmissibility and Mortality of COVID-19 in Europe. Int J Infect Dis. 2020. doi: 10.1016/j.ijid.2020.03.050. PubMed PMID: 32234343; PubMed Central PMCID: PMCPMC7102547.
76
The Guardian [Internet]. How did Spain get its coronavirus response so wrong? [cited 2020 12 April]. Available from: https://www.theguardian.com/world/2020/mar/26/spain-coronavirus-response-analysis
77
Reuters [Internet]. France’s coronavirus death rate accelerates, cases near 100,000. [cited 2020 7 April]. Available from: https://www.reuters.com/article/us-health-coronavirus-france-toll/frances-coronavirus-death-rate-accelerates-cases-near-100000-idUSKBN21O2OX
78
VOX [Internet]. Matthews D. 11 charts that explain the coronavirus pandemic: [cited 2020 18 March]. Available from: https://www.vox.com/future-perfect/2020/3/12/21172040/coronavirus-covid-19-virus-charts
79
The Guardian [Internet]. Italy death toll overtakes China with 3,405 deaths from virus. [cited 2020 19 March]. Available from: https://www.theguardian.com/world/live/2020/mar/19/coronavirus-update-live-news-who-covid19-cases-outbreak-us-states-uk-school-closures-australia-europe-eu-africa-asia-latest-updates?page=with:block-5e73a90f8f088d7575596a4a#block-5e73a90f8f088d7575596a4a
80
NBC bay area [Internet]. Difference Between COVID-19 Cases in CA vs. NY Is Likely Sheer Luck: Experts. [cited 2020 8 April]. Available from: https://www.nbcbayarea.com/news/local/difference-between-covid-19-cases-in-ca-vs-ny-is-likely-sheer-luck-experts/2269934/
81
Bouey J. Strengthening China’s Public Health Response System: From SARS to COVID-19. Am J Public Health. 2020:e1-e2. doi: 10.2105/AJPH.2020.305654. PubMed PMID: 32213081.
82
Khot WY, Nadkar MY. The 2019 Novel Coronavirus Outbreak - A Global Threat. J Assoc Physicians India. 2020;68:67-71. PubMed PMID: 32138488.
83
Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55:105924. doi: 10.1016/j.ijantimicag.2020.105924. PubMed PMID: 32081636; PubMed Central PMCID: PMCPMC7127800.
84
Boldog P, Tekeli T, Vizi Z, Denes A, Bartha FA, Rost G. Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China. J Clin Med. 2020;9. doi: 10.3390/jcm9020571. PubMed PMID: 32093043; PubMed Central PMCID: PMCPMC7073711.
85
Washington Post [Internet]. Why outbreaks like coronavirus spread exponentially, and how to “flatten the curve”. [cited 2020 14 March]. Available from: https://www.washingtonpost.com/graphics/2020/world/corona-simulator/
86
Chen X, Yu B. First two months of the 2019 Coronavirus Disease (COVID-19) epidemic in China: real-time surveillance and evaluation with a second derivative model. Glob Health Res Policy. 2020;5:7. doi: 10.1186/s41256-020-00137-4. PubMed PMID: 32158961; PubMed Central PMCID: PMCPMC7050133.
87
ORIGINAL_ARTICLE
Factors Affecting Patients’ Adherence to Continuous Positive Airway Pressure Therapy for Obstructive Sleep Apnea Disorder: A Multi-Method Approach
Background: Continuous positive airway pressure (CPAP) is the gold standard therapy for treating obstructive sleep apnea (OSA) disorder. However, patients’ adherence to its regular use is poor. The present study aimed to determine the adherence rate to CPAP therapy by identifying factors affecting its regular use and its associated problems and discomforts among a sample population in Mashhad (Iran). Methods: The study was conducted from October 2017 to March 2018 in Mashhad (Iran) using both quantitative and qualitative methods. The quantitative study was carried out using a retrospective cross-sectional data collection from five sleep clinics and one CPAP sales office. The patients were classified into an adherent and a non-adherent group to determine the factors affecting CPAP adherence. Quantitative data were analyzed using SPSS software (version 22.0). Additionally, a prospective qualitative study was performed through a series of telephone interviews using the content analysis method. Qualitative data were analyzed using MAXQDA 10 software.Results: In the quantitative study, the medical records of 159 patients were used, out of which 79 (49.6%) were non-adherent to CPAP therapy. The mean age of all patients was 56.9±9.8 years. The mean body mass index, apnea-hypopnea index, and Epworth sleepiness scale (ESS) scores were 30.9±6.6 kg/m2, 37.2±28.1 events/hour, and 10.4±5.5, respectively. At baseline, the adherent group had a significantly higher age (P=0.006), higher oxygen desaturation index (P=0.006), and lower ESS (P=0.023) compared to the non-adherent group. In the qualitative study, a total of 29 telephone interviews were held with patients from the non-adherent group (8 women and 21 men). Analysis of the interviews resulted in three main categories (level of knowledge, discomfort, and costs) and nine sub-categories. Conclusion: A high percentage of OSA patients had poor adherence to CPAP therapy. Device-related issues could be adequately resolved by providing complementary information during follow-up visits. Moreover, efforts to reduce costs through comprehensive insurance coverage or with government subsidy would improve patients’ adherence to CPAP therapy.
https://ijms.sums.ac.ir/article_45785_ec2f5ca58f6779734273d8f902669aa4.pdf
2020-05-01
170
178
10.30476/ijms.2019.45785
Sleep apnea, obstructive
Continuous positive airway pressure
Patient education as topic
Humans
Iran
Shokoufeh
Aalaei
aalaeish931@mums.ac.ir
1
Department of Medical Informatics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Fariborz
Rezaeitalab
rezaeitalabf@mums.ac.ir
2
Department of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Hamed
Tabesh
tabeshh@mums.ac.ir
3
Department of Medical Informatics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Mahnaz
Amini
aminim@mums.ac.ir
4
Lung Diseases Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Lahya
Afsharisaleh
afsharisl@mums.ac.ir
5
Department of Occupational Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Sayyed Mostafa
Mostafavi
mostafavitm@mums.ac.ir
6
Lung Diseases Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Hadi
Asadpour
asadpourh@mums.ac.ir
7
Sleep Laboratory of Ibn-e-Sina Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Saeid
Eslami
eslamis@mums.ac.ir
8
Department of Medical Informatics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
LEAD_AUTHOR
Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008;5:136-43. doi: 10.1513/pats.200709-155MG. PubMed PMID: 18250205; PubMed Central PMCID: PMCPMC2645248.
1
Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006-14. doi: 10.1093/aje/kws342. PubMed PMID: 23589584; PubMed Central PMCID: PMCPMC3639722.
2
Al Lawati NM, Patel SR, Ayas NT. Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration. Prog Cardiovasc Dis. 2009;51:285-93. doi: 10.1016/j.pcad.2008.08.001. PubMed PMID: 19110130.
3
Rezaeitalab F, Moharrari F, Saberi S, Asadpour H, Rezaeetalab F. The correlation of anxiety and depression with obstructive sleep apnea syndrome. J Res Med Sci. 2014;19:205-10. PubMed PMID: 24949026; PubMed Central PMCID: PMCPMC4061640.
4
Senaratna CV, Perret JL, Lodge CJ, Lowe AJ, Campbell BE, Matheson MC, et al. Prevalence of obstructive sleep apnea in the general population: A systematic review. Sleep Med Rev. 2017;34:70-81. doi: 10.1016/j.smrv.2016.07.002. PubMed PMID: 27568340.
5
Virk JS, Kotecha B. When continuous positive airway pressure (CPAP) fails. J Thorac Dis. 2016;8:E1112-E21. doi: 10.21037/jtd.2016.09.67. PubMed PMID: 27867577; PubMed Central PMCID: PMCPMC5107556.
6
Rotenberg BW, Murariu D, Pang KP. Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol Head Neck Surg. 2016;45:43. doi: 10.1186/s40463-016-0156-0. PubMed PMID: 27542595; PubMed Central PMCID: PMCPMC4992257.
7
Fung CH, Igodan U, Alessi C, Martin JL, Dzierzewski JM, Josephson K, et al. Human factors/usability barriers to home medical devices among individuals with disabling conditions: in-depth interviews with positive airway pressure device users. Disabil Health J. 2015;8:86-92. doi: 10.1016/j.dhjo.2014.06.002. PubMed PMID: 25126995; PubMed Central PMCID: PMCPMC4268236.
8
Kirkham EM, Heckbert SR, Weaver EM. Relationship between Clinical and Polysomnography Measures Corrected for CPAP Use. J Clin Sleep Med. 2015;11:1305-12. doi: 10.5664/jcsm.5192. PubMed PMID: 26194734; PubMed Central PMCID: PMCPMC4623129.
9
Libman E, Bailes S, Fichten CS, Rizzo D, Creti L, Baltzan M, et al. CPAP Treatment Adherence in Women with Obstructive Sleep Apnea. Sleep Disord. 2017;2017:2760650. doi: 10.1155/2017/2760650. PubMed PMID: 28352476; PubMed Central PMCID: PMCPMC5352888.
10
Riachy M, Najem S, Iskandar M, Choucair J, Ibrahim I, Juvelikian G. Factors predicting CPAP adherence in obstructive sleep apnea syndrome. Sleep Breath. 2017;21:295-302. doi: 10.1007/s11325-016-1408-y. PubMed PMID: 27638725.
11
Salepci B, Caglayan B, Kiral N, Parmaksiz ET, Comert SS, Sarac G, et al. CPAP adherence of patients with obstructive sleep apnea. Respir Care. 2013;58:1467-73. doi: 10.4187/respcare.02139. PubMed PMID: 23431305.
12
Baratta F, Pastori D, Bucci T, Fabiani M, Fabiani V, Brunori M, et al. Long-term prediction of adherence to continuous positive air pressure therapy for the treatment of moderate/severe obstructive sleep apnea syndrome. Sleep Med. 2018;43:66-70. doi: 10.1016/j.sleep.2017.09.032. PubMed PMID: 29482815.
13
Borel JC, Tamisier R, Dias-Domingos S, Sapene M, Martin F, Stach B, et al. Type of mask may impact on continuous positive airway pressure adherence in apneic patients. PLoS One. 2013;8:e64382. doi: 10.1371/journal.pone.0064382. PubMed PMID: 23691209; PubMed Central PMCID: PMCPMC3654912.
14
Brostrom A, Nilsen P, Johansson P, Ulander M, Stromberg A, Svanborg E, et al. Putative facilitators and barriers for adherence to CPAP treatment in patients with obstructive sleep apnea syndrome: a qualitative content analysis. Sleep Med. 2010;11:126-30. doi: 10.1016/j.sleep.2009.04.010. PubMed PMID: 20004615.
15
Luyster FS, Dunbar-Jacob J, Aloia MS, Martire LM, Buysse DJ, Strollo PJ. Patient and Partner Experiences With Obstructive Sleep Apnea and CPAP Treatment: A Qualitative Analysis. Behav Sleep Med. 2016;14:67-84. doi: 10.1080/15402002.2014.946597. PubMed PMID: 25203283; PubMed Central PMCID: PMCPMC4363003.
16
Rezaie L, Phillips D, Khazaie H. Barriers to acceptance and adherence to continuous positive airway pressure therapy in patients with obstructive sleep apnea: a report from Kermanshah province, western Iran. Patient Prefer Adherence. 2018;12:1299-304. doi: 10.2147/PPA.S165905. PubMed PMID: 30050292; PubMed Central PMCID: PMCPMC6056160.
17
Afsharpaiman S, Shahverdi E, Vahedi E, Aqaee H. Continuous Positive Airway Pressure Compliance in Patients with Obstructive Sleep Apnea. Tanaffos. 2016;15:25-30. PubMed PMID: 27403175; PubMed Central PMCID: PMCPMC4937758.
18
Roecklein KA, Schumacher JA, Gabriele JM, Fagan C, Baran AS, Richert AC. Personalized feedback to improve CPAP adherence in obstructive sleep apnea. Behav Sleep Med. 2010;8:105-12. doi: 10.1080/15402001003622859. PubMed PMID: 20352546.
19
Budhiraja R, Parthasarathy S, Drake CL, Roth T, Sharief I, Budhiraja P, et al. Early CPAP use identifies subsequent adherence to CPAP therapy. Sleep. 2007;30:320-4. doi: 10.1093/sleep/30.3.320. PubMed PMID: 17425228.
20
Ye L, Pack AI, Maislin G, Dinges D, Hurley S, McCloskey S, et al. Predictors of continuous positive airway pressure use during the first week of treatment. J Sleep Res. 2012;21:419-26. doi: 10.1111/j.1365-2869.2011.00969.x. PubMed PMID: 21988137; PubMed Central PMCID: PMCPMC4476292.
21
Hui DS, Choy DK, Li TS, Ko FW, Wong KK, Chan JK, et al. Determinants of continuous positive airway pressure compliance in a group of Chinese patients with obstructive sleep apnea. Chest. 2001;120:170-6. doi: 10.1378/chest.120.1.170. PubMed PMID: 11451834.
22
Jacobsen AR, Eriksen F, Hansen RW, Erlandsen M, Thorup L, Damgard MB, et al. Determinants for adherence to continuous positive airway pressure therapy in obstructive sleep apnea. PLoS One. 2017;12:e0189614. doi: 10.1371/journal.pone.0189614. PubMed PMID: 29253872; PubMed Central PMCID: PMCPMC5734784.
23
Sawyer AM, Gooneratne NS, Marcus CL, Ofer D, Richards KC, Weaver TE. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev. 2011;15:343-56. doi: 10.1016/j.smrv.2011.01.003. PubMed PMID: 21652236; PubMed Central PMCID: PMCPMC3202028.
24
Wozniak DR, Lasserson TJ, Smith I. Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. Cochrane Database Syst Rev. 2014:CD007736. doi: 10.1002/14651858.CD007736.pub2. PubMed PMID: 24399660.
25
Simon-Tuval T, Reuveni H, Greenberg-Dotan S, Oksenberg A, Tal A, Tarasiuk A. Low socioeconomic status is a risk factor for CPAP acceptance among adult OSAS patients requiring treatment. Sleep. 2009;32:545-52. doi: 10.1093/sleep/32.4.545. PubMed PMID: 19413149; PubMed Central PMCID: PMCPMC2663865.
26
Tarasiuk A, Reznor G, Greenberg-Dotan S, Reuveni H. Financial incentive increases CPAP acceptance in patients from low socioeconomic background. PLoS One. 2012;7:e33178. doi: 10.1371/journal.pone.0033178. PubMed PMID: 22479368; PubMed Central PMCID: PMCPMC3316560.
27
Tran BX, Hwang J, Nguyen LH, Nguyen AT, Latkin NR, Tran NK, et al. Impact of Socioeconomic Inequality on Access, Adherence, and Outcomes of Antiretroviral Treatment Services for People Living with HIV/AIDS in Vietnam. PLoS One. 2016;11:e0168687. doi: 10.1371/journal.pone.0168687. PubMed PMID: 28005937; PubMed Central PMCID: PMCPMC5179124.
28
Stepnowsky CJ, Dimsdale JE. Dose-response relationship between CPAP compliance and measures of sleep apnea severity. Sleep Med. 2002;3:329-34. PubMed PMID: 14592195.
29
Kohler M, Smith D, Tippett V, Stradling JR. Predictors of long-term compliance with continuous positive airway pressure. Thorax. 2010;65:829-32. doi: 10.1136/thx.2010.135848. PubMed PMID: 20805182.
30
Lewis KE, Seale L, Bartle IE, Watkins AJ, Ebden P. Early predictors of CPAP use for the treatment of obstructive sleep apnea. Sleep. 2004;27:134-8. doi: 10.1093/sleep/27.1.134. PubMed PMID: 14998250.
31
Kim JH, Kwon MS, Song HM, Lee BJ, Jang YJ, Chung YS. Compliance with positive airway pressure treatment for obstructive sleep apnea. Clin Exp Otorhinolaryngol. 2009;2:90-6. doi: 10.3342/ceo.2009.2.2.90. PubMed PMID: 19565034; PubMed Central PMCID: PMCPMC2702727.
32
Soltaninejad F, Sadeghi A, Amra B. Compliance with continuous positive airway pressure in Persian patients with obstructive sleep apnea. J Res Med Sci. 2017;22:114. doi: 10.4103/jrms.JRMS_108_17. PubMed PMID: 29184572; PubMed Central PMCID: PMCPMC5680659.
33
Scalzitti N, Hansen S, Maturo S, Lospinoso J, O’Connor P. Comparison of home sleep apnea testing versus laboratory polysomnography for the diagnosis of obstructive sleep apnea in children. Int J Pediatr Otorhinolaryngol. 2017;100:44-51. doi: 10.1016/j.ijporl.2017.06.013. PubMed PMID: 28802385.
34
ORIGINAL_ARTICLE
The Persian Handwriting Assessment Tool for Primary School-Aged Children: Further Validation
Background: Handwriting problems are one of the common problems among students in the early years of education. The current study aimed to determine further validation aspects of the Persian Handwriting Assessment Tool (PHAT) in primary school-aged children.Methods: The current methodological study was conducted on 452 healthy 8-10-year-old students in Tehran, Iran, selected via random cluster sampling method. Inclusion criteria were native Persian-speaking and no documented physical and mental impairments. Construct and structural validities were established by exploratory factor analysis (EFA) using principal axis factoring with Promax rotation and confirmatory factor analysis (CFA), respectively. Criterion validity was examined by expert opinion as the gold standard using Pearson correlation test. Internal consistency, test-retest, and inter-rater reliability were examined using Cronbach’s alpha and intra-class correlation (ICC). Test-retest had a seven-day interval.Results: The EFA results indicated two separate factors in the copying and dictation domains. Speed and orthographic error and size were considered as separate items. The CFA confirmed the factor structure. Criterion validity revealed low to moderate correlation (formation: 0.548, p <0.001; 0.503, p <0.001, spacing: 0.553, p <0.001; 0.307, P=0.030, alignment: 0.442, p <0.001; 0.358, P=0.011, size: -0.376, P=0.007; -0.445, p <0.001, and slant: 0.360, P=0.010; 0.372, P=0.008) in copying and dictation domain, respectively. Acceptable internal consistency (Cronbach’s alpha: 0.72-0.99), excellent test-retest (ICC: 0.76-0.99), excellent inter-rater reliability between teachers (ICC: 0.86-0.95), and good to excellent inter-rater reliability between teachers and the occupational therapist (ICC: 0.60-0.95) were reported.Conclusion: The results indicated that the PHAT was a valid and reliable tool for assessing handwriting in primary school-aged children.
https://ijms.sums.ac.ir/article_45786_844df5670bb1a39c2460f7874529d87c.pdf
2020-05-01
179
187
10.30476/ijms.2019.45786
Educational measurement
Handwriting
Schools
Validation studies
Mahsa
Meimandi
1
Rehabilitation Research Center, Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran
AUTHOR
Akram
Azad
azad.a@iums.ac.ir
2
Rehabilitation Research Center, Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran
LEAD_AUTHOR
Naser
Havaei
3
Department of Occupational Therapy, School of Rehabilitation, Tabriz University of Medical Sciences, Tabriz, Iran
AUTHOR
Armin
Zareiyan
4
Department of Community and Public Health, Nursing Faculty, AJA University of Medical Science, Tehran, Iran
AUTHOR
Wicki W, Hurschler Lichtsteiner S. Improvement of handwriting automaticity among children treated for graphomotor difficulties over a period of six months. J Occup Ther Sch Early Interv. 2018;11:148-60. doi: 10.1080/19411243.2018.1432440.
1
Falk TH, Tam C, Schellnus H, Chau T. On the development of a computer-based handwriting assessment tool to objectively quantify handwriting proficiency in children. Comput Methods Programs Biomed. 2011;104:e102-11. doi: 10.1016/j.cmpb.2010.12.010. PubMed PMID: 21376418.
2
Rosenblum S. Development, reliability, and validity of the Handwriting Proficiency Screening Questionnaire (HPSQ). Am J Occup Ther. 2008;62:298-307. doi: 10.5014/ajot.62.3.298. PubMed PMID: 18557006.
3
Martins MR, Bastos JA, Cecato AT, Araujo Mde L, Magro RR, Alaminos V. Screening for motor dysgraphia in public schools. J Pediatr (Rio J). 2013;89:70-4. doi: 10.1016/j.jped.2013.02.011. PubMed PMID: 23544813.
4
Barnett AL, Prunty M, Rosenblum S. Development of the Handwriting Legibility Scale (HLS): A preliminary examination of Reliability and Validity. Res Dev Disabil. 2018;72:240-7. doi: 10.1016/j.ridd.2017.11.013. PubMed PMID: 29223112.
5
Shehni YM, Karami J, Shokrkon H, Mehrabizadeh Honarmand M. Prevalence of dysgraphia and the effects of multi-sense therapy on reduction of writing difficulties of primary school students in Ahvaz. Journal of Education and Psychology. 2004;10:17-38.
6
Feder K, Majnemer A, Synnes A. Handwriting: current trends in occupational therapy practice. Can J Occup Ther. 2000;67:197-204. doi: 10.1177/000841740006700313. PubMed PMID: 10914482.
7
Overvelde A, Hulstijn W. Handwriting development in grade 2 and grade 3 primary school children with normal, at risk, or dysgraphic characteristics. Res Dev Disabil. 2011;32:540-8. doi: 10.1016/j.ridd.2010.12.027. PubMed PMID: 21269805.
8
Rosenblum S, Weiss PL, Parush S. Product and process evaluation of handwriting difficulties. Educ Psychol Rev. 2003;15:41-81.
9
Feder KP, Majnemer A. Children’s handwriting evaluation tools and their psychometric properties. Phys Occup Ther Pediatr. 2003;23:65-84. doi: 10.1080/j006v23n03_05. PubMed PMID: 14664312.
10
Li-Tsang CW, Wong AS, Leung HW, Cheng JS, Chiu BH, Tse LF, et al. Validation of the Chinese Handwriting Analysis System (CHAS) for primary school students in Hong Kong. Res Dev Disabil. 2013;34:2872-83. doi: 10.1016/j.ridd.2013.05.048. PubMed PMID: 23816625.
11
Roston KL, Hinojosa J, Kaplan H. Using the Minnesota Handwriting Assessment and Handwriting Checklist in screening first and second graders’ handwriting legibility. J Occup Ther Sch Early Interv. 2008;1:100-15. doi: 10.1080/19411240802312947.
12
Koziatek SM, Powell NJ. A validity study of the Evaluation Tool of Children’s Handwriting-Cursive. Am J Occup Ther. 2002;56:446-53. doi: 10.5014/ajot.56.4.446. PubMed PMID: 12125834.
13
Solimanpour F, Sadri J, Suen CY, editors. Standard databases for recognition of handwritten digits, numerical strings, legal amounts, letters and dates in Farsi languag. 23 October 2006. La Baule: Suvisoft. Tenth International Workshop on Frontiers in Handwriting Recognition.
14
Havaei N, Azad A, Zarei MA, Ebadi A. Development and Validity of the Persian Handwriting Assessment Tool for Primary School-Aged Children. Iran Red Crescent Med J. 2017;19:e40508. doi: 10.5812/ircmj.40508.
15
Havaei N, Azad A, Alizadeh-Zarei M, Ebadi A. Reliability of Persian Handwriting Assessment Tool in Iranian primary school students. Iranian Rehabilitation Journal. 2018;16:353-60. doi: 10.32598/irj.16.4.353.
16
Brown TA. Confirmatory factor analysis for applied research. New York: Guilford publications; 2015.
17
Tabachnick BG, Fidell LS, Ullman JB. Using multivariate statistics. 5th ed. Boston: Allyn & Bacon/Pearson Education; 2007.
18
Plichta SB, Kelvin EA, Munro BH. Munro’s statistical methods for health care research. 5th edition. London: Wolters Kluwer Health/Lippincott Williams & Wilkins. 2013.
19
Hooper D, Coughlan J, Mullen M. Structural equation modelling: Guidelines for determining model fit. Electronic Journal of Business Research Methods. 2008;6:53-60.
20
Schreiber JB, Nora A, Stage FK, Barlow EA, King J. Reporting structural equation modeling and confirmatory factor analysis results: A review. J Educ Res. 2006;99:323-38. doi: 10.3200/JOER.99.6.323-338.
21
Polit DF, Yang F. Measurement and the measurement of change: a primer for the health professions. New York: Wolters Kluwer Health; 2015.
22
Carter R, Lubinsky J. Rehabilitation research-e-book: Principles and applications. 4th ed. New York: Elsevier Health Sciences; 2015.
23
Gillespie DF, Perron BE. Key Concepts in Measurement. Oxford: Oxford University Press; 2015.
24
Diekema SM, Deitz J, Amundson SJ. Test-retest reliability of the evaluation tool of children’s handwriting-manuscript. Am J Occup Ther. 1998;52:248-55. doi: 10.5014/ajot.52.4.248. PubMed PMID: 9544349.
25
McDowell I. Measuring health: a guide to rating scales and questionnaires. 3th ed. Oxford: Oxford University Press; 2006.
26
de Vet HC, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine: a practical guide. Cambridge: Cambridge University Press; 2011.
27
Yong AG, Pearce S. A beginner’s guide to factor analysis: Focusing on exploratory factor analysis. Tutor Quant Methods Psychol. 2013;9:79-94. doi: 10.20982/tqmp.09.2.p079.
28
Feder KP, Majnemer A. Handwriting development, competency, and intervention. Dev Med Child Neurol. 2007;49:312-7. doi: 10.1111/j.1469-8749.2007.00312.x. PubMed PMID: 17376144.
29
Graham S, Boyer-Shick K, Tippets E. The validity of the handwriting scale from the test of written language. J Educ Res. 1989;82:166-71. doi: 10.1080/00220671.1989.10885886.
30
Hammerschmidt SL, Sudsawad P. Teachers’ survey on problems with handwriting: referral, evaluation, and outcomes. Am J Occup Ther. 2004;58:185-92. doi: 10.5014/ajot.58.2.185. PubMed PMID: 15068154.
31
Ziviani J, Elkins J. An evaluation of handwriting performance. Educ Rev. 1984;36:249-61. doi: 10.1080/0013191840360304.
32
Daniel ME, Froude EH. Reliability of occupational therapist and teacher evaluations of the handwriting quality of grade 5 and 6 primary school children. Aust Occup Ther J. 1998;45:48-58. doi: 10.1111/j.1440-1630.1998.tb00782.x.
33
ORIGINAL_ARTICLE
The Effects of EGTA on the Quality of Fresh and Cryopreserved-Thawed Human Spermatozoa
Background: Sperm cryopreservation-thawing process has damaging effects on the structure and function of sperm, namely cryoinjury. Calcium overload has been reported as a postulated mechanism for sperm damage during the first steps after thawing. This study was designed to assess the intracellular calcium (Ca2+i) after cryopreservation and to clarify the role of a calcium chelator ethylene glycol-bis (2-aminoethyl ether)-N, N, N′, N′-tetraacetic acid (EGTA) on human sperm quality.Methods: Forty semen samples were obtained from fertile men (March 2017 to 2018). The samples were randomly divided into fresh (F) and cryopreserved-thawed (CT) groups. The F and CT samples were divided into control and 1 mM EGTA-treated groups. Sperm kinematics and membrane integrity were assessed. The reactive oxygen species (ROS) and adenosine triphosphate (ATP) were measured by luminescent methods. Ca2+i, apoptotic rate, and mitochondrial membrane potential (MMP) were evaluated using flow cytometric methods. Data were compared using SPSS software, version 16.0 by ANOVA and Kruskal-Wallis test. PResults: Cryopreservation decreased sperm motility, viability, membrane integrity, Ca2+i, MMP, and induced cell apoptosis and ROS production. EGTA could not protect the cryopreserved sperm from cryoinjury. It was found to have destructive effects on fresh sperm motility and viability (P=0.009) relative to cryopreserved sperm. ATP was reduced (P=0.02) and ROS production (P=0.0001) was increased in the EGTA-treated F and CT sperms.Conclusion: Despite Ca2+i reduction by EGTA, it had no protective effects on fresh or cryopreserved sperm. We concluded that sperm cryoinjury was not dependent on calcium overload, and it was suggested that cryoinjury was mainly related to cell membranes damage.
https://ijms.sums.ac.ir/article_45787_f707f03682a0d85aaea409a8d69e8805.pdf
2020-05-01
188
198
10.30476/ijms.2019.45787
Spermatozoa
Cryopreservation
Calcium
Egtazic acid
Bahareh
Ebrahimi
ebrahimi_b@sums.ac.ir
1
Department of Physiology, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
AUTHOR
Sara
Keshtgar
keshtgar@sums.ac.ir
2
Department of Physiology, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
LEAD_AUTHOR
Visconti PE. Understanding the molecular basis of sperm capacitation through kinase design. Proc Natl Acad Sci U S A. 2009;106:667-8. doi: 10.1073/pnas.0811895106. PubMed PMID: 19144927; PubMed Central PMCID: PMCPMC2630107.
1
Rahman MS, Kwon WS, Pang MG. Calcium influx and male fertility in the context of the sperm proteome: an update. Biomed Res Int. 2014;2014:841615. doi: 10.1155/2014/841615. PubMed PMID: 24877140; PubMed Central PMCID: PMCPMC4022195.
2
Li K, Xue Y, Chen A, Jiang Y, Xie H, Shi Q, et al. Heat shock protein 90 has roles in intracellular calcium homeostasis, protein tyrosine phosphorylation regulation, and progesterone-responsive sperm function in human sperm. PLoS One. 2014;9:e115841. doi: 10.1371/journal.pone.0115841. PubMed PMID: 25541943; PubMed Central PMCID: PMCPMC4277372.
3
Sumigama S, Mansell S, Miller M, Lishko PV, Cherr GN, Meyers SA, et al. Progesterone Accelerates the Completion of Sperm Capacitation and Activates CatSper Channel in Spermatozoa from the Rhesus Macaque. Biol Reprod. 2015;93:130. doi: 10.1095/biolreprod.115.129783. PubMed PMID: 26490839; PubMed Central PMCID: PMCPMC4712691.
4
Lishko PV, Kirichok Y. The role of Hv1 and CatSper channels in sperm activation. J Physiol. 2010;588:4667-72. doi: 10.1113/jphysiol.2010.194142. PubMed PMID: 20679352; PubMed Central PMCID: PMCPMC3010136.
5
Tamburrino L, Marchiani S, Minetti F, Forti G, Muratori M, Baldi E. The CatSper calcium channel in human sperm: relation with motility and involvement in progesterone-induced acrosome reaction. Hum Reprod. 2014;29:418-28. doi: 10.1093/humrep/det454. PubMed PMID: 24430778.
6
Torres-Flores V, Picazo-Juarez G, Hernandez-Rueda Y, Darszon A, Gonzalez-Martinez MT. Sodium influx induced by external calcium chelation decreases human sperm motility. Hum Reprod. 2011;26:2626-35. doi: 10.1093/humrep/der237. PubMed PMID: 21810864; PubMed Central PMCID: PMCPMC3174032.
7
Li D, Cao W. Role of intracellular calcium and NADPH oxidase NOX5-S in acid-induced DNA damage in Barrett’s cells and Barrett’s esophageal adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol. 2014;306:G863-72. doi: 10.1152/ajpgi.00321.2013. PubMed PMID: 24699332; PubMed Central PMCID: PMCPMC4024726.
8
Guthrie HD, Welch GR, Theisen DD, Woods LC, 3rd. Effects of hypothermic storage on intracellular calcium, reactive oxygen species formation, mitochondrial function, motility, and plasma membrane integrity in striped bass (Morone saxatilis) sperm. Theriogenology. 2011;75:951-61. doi: 10.1016/j.theriogenology.2010.10.037. PubMed PMID: 21247623.
9
Hajnoczky G, Csordas G, Das S, Garcia-Perez C, Saotome M, Sinha Roy S, et al. Mitochondrial calcium signalling and cell death: approaches for assessing the role of mitochondrial Ca2+ uptake in apoptosis. Cell Calcium. 2006;40:553-60. doi: 10.1016/j.ceca.2006.08.016. PubMed PMID: 17074387; PubMed Central PMCID: PMCPMC2692319.
10
Giorgi C, Marchi S, Pinton P. The machineries, regulation and cellular functions of mitochondrial calcium. Nat Rev Mol Cell Biol. 2018;19:713-30. doi: 10.1038/s41580-018-0052-8. PubMed PMID: 30143745.
11
Bernardi P, Forte M. The mitochondrial permeability transition pore. Novartis Found Symp. 2007;287:157-64. doi: 10.1002/9780470725207.ch11. PubMed PMID: 18074637.
12
Peng TI, Jou MJ. Oxidative stress caused by mitochondrial calcium overload. Ann N Y Acad Sci. 2010;1201:183-8. doi: 10.1111/j.1749-6632.2010.05634.x. PubMed PMID: 20649555.
13
Treulen F, Arias ME, Aguila L, Uribe P, Felmer R. Cryopreservation induces mitochondrial permeability transition in a bovine sperm model. Cryobiology. 2018;83:65-74. doi: 10.1016/j.cryobiol.2018.06.001. PubMed PMID: 29864412.
14
Ozkavukcu S, Erdemli E, Isik A, Oztuna D, Karahuseyinoglu S. Effects of cryopreservation on sperm parameters and ultrastructural morphology of human spermatozoa. J Assist Reprod Genet. 2008;25:403-11. doi: 10.1007/s10815-008-9232-3. PubMed PMID: 18704674; PubMed Central PMCID: PMCPMC2582121.
15
Saeednia S, Bahadoran H, Amidi F, Asadi MH. Impact of Cryopreservation Process on Viability, Nitric Oxide and DNA Apoptosis in Fertile Human Spermatozoa. Anatomical Sciences Journal. 2013;10:17-23.
16
Zhang W, Li F, Cao H, Li C, Du C, Yao L, et al. Protective effects of l-carnitine on astheno- and normozoospermic human semen samples during cryopreservation. Zygote. 2016;24:293-300. doi: 10.1017/S0967199415000180. PubMed PMID: 26081351.
17
Albrizio M, Moramarco AM, Nicassio M, Micera E, Zarrilli A, Lacalandra GM. Localization and functional modification of L-type voltage-gated calcium channels in equine spermatozoa from fresh and frozen semen. Theriogenology. 2015;83:421-9. doi: 10.1016/j.theriogenology.2014.10.005. PubMed PMID: 25459425.
18
Kumaresan A, Siqueira AP, Hossain MS, Johannisson A, Eriksson I, Wallgren M, et al. Quantification of kinetic changes in protein tyrosine phosphorylation and cytosolic Ca(2)(+) concentration in boar spermatozoa during cryopreservation. Reprod Fertil Dev. 2012;24:531-42. doi: 10.1071/RD11074. PubMed PMID: 22541541.
19
Wang S, Wang W, Xu Y, Tang M, Fang J, Sun H, et al. Proteomic characteristics of human sperm cryopreservation. Proteomics. 2014;14:298-310. doi: 10.1002/pmic.201300225. PubMed PMID: 24259508.
20
Xie Z, Zhang Y, Li A, Li P, Ji W, Huang D. Cd-induced apoptosis was mediated by the release of Ca2+ from intracellular Ca storage. Toxicol Lett. 2010;192:115-8. doi: 10.1016/j.toxlet.2009.10.011. PubMed PMID: 19853025.
21
Fong JC, Lin CH, Wei YH, Ho LT, Hong CY. Calcium buffering capacity of human seminal plasma: the role of EGTA in stimulating sperm motility. Chin J Physiol. 1986;29:7-12. PubMed PMID: 3093172.
22
Yeste M, Fernandez-Novell JM, Ramio-Lluch L, Estrada E, Rocha LG, Cebrian-Perez JA, et al. Intracellular calcium movements of boar spermatozoa during ‘in vitro’ capacitation and subsequent acrosome exocytosis follow a multiple-storage place, extracellular calcium-dependent model. Andrology. 2015;3:729-47. doi: 10.1111/andr.12054. PubMed PMID: 26097097.
23
Domingo P, Olaciregui M, Gonzalez N, De Blas I, Gil L. Long-term preservation of freeze-dried rabbit sperm by adding rosmarinic acid and different chelating agents. Cryobiology. 2018;81:174-7. doi: 10.1016/j.cryobiol.2018.01.004. PubMed PMID: 29366763.
24
Okazaki T, Yoshida S, Teshima H, Shimada M. The addition of calcium ion chelator, EGTA to thawing solution improves fertilizing ability in frozen-thawed boar sperm. Anim Sci J. 2011;82:412-9. doi: 10.1111/j.1740-0929.2010.00856.x. PubMed PMID: 21615834.
25
Keshtgar S, Iravanpour F, Gharesi-Fard B, Kazerooni M. Combined Effect of Trolox and EDTA on Frozen-Thawed Sperm Quality. Iran J Med Sci. 2016;41:230-7. PubMed PMID: 27217608; PubMed Central PMCID: PMCPMC4876302.
26
Bondarenko O, Dzyuba B, Rodina M, Cosson J. Role of Ca(2+) in the IVM of spermatozoa from the sterlet Acipenser ruthenus. Reprod Fertil Dev. 2017;29:1319-28. doi: 10.1071/RD16145. PubMed PMID: 27246727.
27
Alavi SM, Gela D, Rodina M, Linhart O. Roles of osmolality, calcium - Potassium antagonist and calcium in activation and flagellar beating pattern of sturgeon sperm. Comp Biochem Physiol A Mol Integr Physiol. 2011;160:166-74. doi: 10.1016/j.cbpa.2011.05.026. PubMed PMID: 21651987.
28
Wei C, Zhang Y, Li R, Wang S, Wang T, Liu J, et al. Terahertz irradiation-induced motility enhancement and intracellular calcium elevation in human sperm in vitro. Biomed Opt Express. 2018;9:3998-4008. doi: 10.1364/BOE.9.003998. PubMed PMID: 30615720; PubMed Central PMCID: PMCPMC6157776.
29
Lee CH, Anderson M, Chien YW. Characterization of in-vitro spermicidal activity of chelating agent against human sperm. J Pharm Sci. 1996;85:649-54. doi: 10.1021/js9501573. PubMed PMID: 8773964.
30
Organization WH. WHO laboratory manual for the examination and processing of human semen. Geneva: World Health Organization; 2010.
31
Ghanbari H, Keshtgar S, Kazeroni M. Inhibition of the CatSper Channel and NOX5 Enzyme Activity Affects the Functions of the Progesterone-Stimulated Human Sperm. Iran J Med Sci. 2018;43:18-25. PubMed PMID: 29398748; PubMed Central PMCID: PMCPMC5775990.
32
Kumaresan A, Gonzalez R, Johannisson A, Berqvist AS. Dynamic quantification of intracellular calcium and protein tyrosine phosphorylation in cryopreserved boar spermatozoa during short-time incubation with oviductal fluid. Theriogenology. 2014;82:1145-53. doi: 10.1016/j.theriogenology.2014.07.029. PubMed PMID: 25175760.
33
Suarez SS. Control of hyperactivation in sperm. Hum Reprod Update. 2008;14:647-57. doi: 10.1093/humupd/dmn029. PubMed PMID: 18653675.
34
Alasmari W, Costello S, Correia J, Oxenham SK, Morris J, Fernandes L, et al. Ca2+ signals generated by CatSper and Ca2+ stores regulate different behaviors in human sperm. J Biol Chem. 2013;288:6248-58. doi: 10.1074/jbc.M112.439356. PubMed PMID: 23344959; PubMed Central PMCID: PMCPMC3585060.
35
Gagnon C, de Lamirande E. Controls of sperm motility. The sperm cell: production, maturation, fertilization, regeneration. 2006:108-33.
36
Piomboni P, Focarelli R, Stendardi A, Ferramosca A, Zara V. The role of mitochondria in energy production for human sperm motility. Int J Androl. 2012;35:109-24. doi: 10.1111/j.1365-2605.2011.01218.x. PubMed PMID: 21950496.
37
Kaneko T, Kimura S, Nakagata N. Offspring derived from oocytes injected with rat sperm, frozen or freeze-dried without cryoprotection. Theriogenology. 2007;68:1017-21. doi: 10.1016/j.theriogenology.2007.07.017. PubMed PMID: 17804050.
38
Kusakabe H, Szczygiel MA, Whittingham DG, Yanagimachi R. Maintenance of genetic integrity in frozen and freeze-dried mouse spermatozoa. Proc Natl Acad Sci U S A. 2001;98:13501-6. doi: 10.1073/pnas.241517598. PubMed PMID: 11707598; PubMed Central PMCID: PMCPMC61070.
39
Feissner RF, Skalska J, Gaum WE, Sheu SS. Crosstalk signaling between mitochondrial Ca2+ and ROS. Front Biosci (Landmark Ed). 2009;14:1197-218. doi: 10.2741/3303. PubMed PMID: 19273125; PubMed Central PMCID: PMCPMC2683671.
40
Rasola A, Bernardi P. Mitochondrial permeability transition in Ca(2+)-dependent apoptosis and necrosis. Cell Calcium. 2011;50:222-33. doi: 10.1016/j.ceca.2011.04.007. PubMed PMID: 21601280.
41
Men NT, Kikuchi K, Nakai M, Fukuda A, Tanihara F, Noguchi J, et al. Effect of trehalose on DNA integrity of freeze-dried boar sperm, fertilization, and embryo development after intracytoplasmic sperm injection. Theriogenology. 2013;80:1033-44. doi: 10.1016/j.theriogenology.2013.08.001. PubMed PMID: 24041826.
42
Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol. 2004;287:C817-33. doi: 10.1152/ajpcell.00139.2004. PubMed PMID: 15355853.
43
Torres-Flores V, Garcia-Sanchez NL, Gonzalez-Martinez MT. Intracellular sodium increase induced by external calcium removal in human sperm. J Androl. 2008;29:63-9. doi: 10.2164/jandrol.107.003368. PubMed PMID: 17673433.
44
ORIGINAL_ARTICLE
Effects of Heracleum Persicum Hydroalcoholic Extract on Insulin, Serum Anti-Oxidant Enzymes, Glucose, and Lipid Profiles in Alloxan-Induced Diabetic Rats
Background: Heracleum persicum (H. persicum) is a medicinal herb used in Iranian traditional medicine for its anti-toxic property. It is commonly consumed in the form of food additives and as a medicinal herbal tonic to treat liver and kidney diseases. The present study aimed to investigate the anti-oxidant, anti-diabetic, and anti-hyperlipidemic effects of H. persicum hydroalcoholic extract in alloxan-induced diabetic rats. Methods: Adult male Wistar rats (n=30) were assigned to five groups: a normal group, a diabetic control group, and three diabetic groups treated orally with 200 and 400 mg/kg of the extract and 5 mg/kg of glibenclamide, respectively, for two weeks. Blood glucose and bodyweight were measured at the end of each week. On day 15, blood samples were collected to measure the levels of insulin, insulin growth factor-I (IGF-I), antioxidant markers for malondialdehyde (MDA), glutathione peroxidase (GPx), superoxide dismutase (SOD), total antioxidant activity (TAS), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL), low-density lipoprotein (LDL), and very low-density lipoprotein (VLDL) using commercial kits. The data were analyzed using SPSS Software (version 22.0).Results: Daily treatment with 400 mg/kg of the extract significantly reduced the blood glucose level (p <0.001) and improved bodyweight (P=0.002), insulin (p <0.001), IGF-I (P=0.024), SOD (P=0.001), GPx (P=0.009), MDA (p <0.001), TAS (P=0.006), TG (p <0.001), HDL (P=0.023), LDL (P=0.005), and VLDL (p <0.001) compared with the diabetic control group. Conclusion: Beneficial effects of H. persicum for the treatment of diabetes were confirmed.
https://ijms.sums.ac.ir/article_45805_f058e3114ebc1fb6767a1f487e49339f.pdf
2020-05-01
199
206
10.30476/ijms.2019.45805
Heracleum persicum
Antioxidants
Blood glucose
diabetes mellitus
Insulin
Insulin-like growth factor I
Zahra
Majidi
zahra.majidii69@gmail.com
1
Department of Traditional Pharmacy, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Seyede Nargess
Sadati lamardi
n_sadati@tums.ac.ir
2
Department of Traditional Pharmacy, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran
LEAD_AUTHOR
Alireza
Mohajjel-Nayebi
nayebia@yahoo.com
3
Drug Applied Research Center, Department of Pharmacology and Toxicology, Tabriz University of Medical Sciences, Tabriz, Iran
AUTHOR
Amir Mansour
Vatankhah
amvatankhah1972@gmail.com
4
Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
AUTHOR
Solmaz
Asnaashari
asnaasharisolmaz@gmail.com
5
Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
AUTHOR
Parvin
Zakeri-Milani
pzakeri@tbzmed.ac.ir
6
Liver and Gastrointestinal Diseases Research Center, Department of Pharmaceutics and School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
AUTHOR
Ozougwu J, Obimba K, Belonwu C, Unakalamba C. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. Journal of Physiology and Pathophysiology. 2013;4:46-57. doi: 10.5897/JPAP2013.0001.
1
Thévenod F. Pathophysiology of diabetes mellitus type 2: roles of obesity, insulin resistance and β-cell dysfunction. Diabetes and Cancer. 2008;19:1-18. doi: 10.1159/000152019.
2
Chukwunonso Obi B, Chinwuba Okoye T, Okpashi VE, Nonye Igwe C, Olisah Alumanah E. Comparative Study of the Antioxidant Effects of Metformin, Glibenclamide, and Repaglinide in Alloxan-Induced Diabetic Rats. J Diabetes Res. 2016;2016:1635361. doi: 10.1155/2016/1635361. PubMed PMID: 26824037; PubMed Central PMCID: PMCPMC4707348.
3
Lee SY, Park SL, Hwang JT, Yi SH, Nam YD, Lim SI. Antidiabetic Effect of Morinda citrifolia (Noni) Fermented by Cheonggukjang in KK-A(y) Diabetic Mice. Evid Based Complement Alternat Med. 2012;2012:163280. doi: 10.1155/2012/163280. PubMed PMID: 22969823; PubMed Central PMCID: PMCPMC3434424.
4
Venkatesh S, Madhava Reddy B, Dayanand Reddy G, Mullangi R, Lakshman M. Antihyperglycemic and hypolipidemic effects of Helicteres isora roots in alloxan-induced diabetic rats: a possible mechanism of action. J Nat Med. 2010;64:295-304. doi: 10.1007/s11418-010-0406-9. PubMed PMID: 20238178.
5
Fröberg L. Heracleum L. Flora Nordica (Thymelaeaceae to Apiaceae). Stockholm: The Swedish Museum of Natural History; 2010. p. 224-34.
6
Aghili M. Makhzan-al-Advia. In: Rahimi R, Shams Ardekani MR, Farjadmand F, editors. Tehran: Tehran University of Medical Sciences; 2009. p. 201-2. Persian.
7
Sharififar F, Pournourmohammadi S, Rastegarianzadeh R, Ranjbaran O, Purhemmaty A. Immunomodulatory activity of aqueous extract of Heracleum persicum Desf. in mice. Iran J Pharm Res. 2010;8:287-92.
8
Sayyah M, Moaied S, Kamalinejad M. Anticonvulsant activity of Heracleum persicum seed. J Ethnopharmacol. 2005;98:209-11. doi: 10.1016/j.jep.2004.12.026. PubMed PMID: 15763386.
9
Aynehchi Y, Aliabadi Z, Salehi Surmaghi MH. Furanocoumarines in the roots of Heracleum persicum DESF. Acta Horticulture. 1978;73:103-8. doi: 10.17660/ActaHortic.1978.73.13.
10
Radjabian T, Salimi A, Rahmani N. Essential-oil composition of the fruits of six Heracleum L. species from Iran: chemotaxonomic significance. Chem Biodivers. 2014;11:1945-53. doi: 10.1002/cbdv.201400085. PubMed PMID: 25491338.
11
Tunçtürk M, Özgökçe F. Chemical composition of some Apiaceae plants commonly used in herby cheese in Eastern Anatolia. Turkish Journal of Agriculture and Forestry. 2015;39:55-62. doi: /10.3906/tar-1406-153.
12
Dehghan H, Sarrafi Y, Salehi P. Antioxidant and antidiabetic activities of 11 herbal plants from Hyrcania region, Iran. J Food Drug Anal. 2016;24:179-88. doi: 10.1016/j.jfda.2015.06.010. PubMed PMID: 28911402.c
13
Hajhashemi V, Sajjadi SE, Heshmati M. Anti-inflammatory and analgesic properties of Heracleum persicum essential oil and hydroalcoholic extract in animal models. J Ethnopharmacol. 2009;124:475-80. doi: 10.1016/j.jep.2009.05.012. PubMed PMID: 19467316.
14
Panahi Y, Pishgoo B, Dadjoo Y, Saburi A. OP-140 the effects of heracleum persicum extract as an adjunctive therapy on dyslipidemia; a randomized open-label clinical trial. Int J Cardiol. 2013;163:S55. doi: 10.1016/S0167-5273(13)70141-4.
15
Olfert ED, Cross BM, McWilliam AA. Guide to the care and use of experimental animals Vol 1. 2nd ed. Ottawa: McWilliam; 1983.
16
Ahmed S, Mundhe N, Borgohain M, Chowdhury L, Kwatra M, Bolshette N, et al. Diosmin Modulates the NF-kB Signal Transduction Pathways and Downregulation of Various Oxidative Stress Markers in Alloxan-Induced Diabetic Nephropathy. Inflammation. 2016;39:1783-97. doi: 10.1007/s10753-016-0413-4. PubMed PMID: 27492452.
17
Kim U, Lee T. Topography of descending projections from anterior insular and medial prefrontal regions to the lateral habenula of the epithalamus in the rat. Eur J Neurosci. 2012;35:1253-69. doi: 10.1111/j.1460-9568.2012.08030.x. PubMed PMID: 22512256.
18
Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158-69. PubMed PMID: 6066618.
19
Crosti N, Servidei T, Bajer J, Serra A. Modification of the 6-hydroxydopamine technique for the correct determination of superoxide dismutase. J Clin Chem Clin Biochem. 1987;25:265-6. PubMed PMID: 3114411.
20
Jowko E, Dlugolecka B, Makaruk B, Cieslinski I. The effect of green tea extract supplementation on exercise-induced oxidative stress parameters in male sprinters. Eur J Nutr. 2015;54:783-91. doi: 10.1007/s00394-014-0757-1. PubMed PMID: 25120110; PubMed Central PMCID: PMCPMC4500852.
21
Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-8. doi: 10.1016/0003-2697(79)90738-3. PubMed PMID: 36810.
22
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502. PubMed PMID: 4337382.
23
Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001;50:537-46. PubMed PMID: 11829314.
24
Patel DK, Prasad SK, Kumar R, Hemalatha S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed. 2012;2:320-30. doi: 10.1016/S2221-1691(12)60032-X. PubMed PMID: 23569923; PubMed Central PMCID: PMCPMC3609288.
25
Coman C, Rugina OD, Socaciu C. Plants and natural compounds with antidiabetic action. Not Bot Horti Agrobot Cluj Napoca. 2012;40:314-25.
26
Zhang Y, Liu D. Flavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory function. Eur J Pharmacol. 2011;670:325-32. doi: 10.1016/j.ejphar.2011.08.011. PubMed PMID: 21914439.
27
Cao H, Ji Y, Li W, Liu Y, Fu R, Xiang M. Protective Effects of the Total Coumarin Fraction of Urtica dentata on Experimental Diabetic Nephropathy In Vitro and In Vivo. Planta Med. 2015;81:1353-60. doi: 10.1055/s-0035-1557866. PubMed PMID: 26366750.
28
Kang KS, Lee W, Jung Y, Lee JH, Lee S, Eom DW, et al. Protective effect of esculin on streptozotocin-induced diabetic renal damage in mice. J Agric Food Chem. 2014;62:2069-76. doi: 10.1021/jf403840c. PubMed PMID: 24484395.
29
Hui H, Tang G, Go VL. Hypoglycemic herbs and their action mechanisms. Chin Med. 2009;4:11. doi: 10.1186/1749-8546-4-11. PubMed PMID: 19523223; PubMed Central PMCID: PMCPMC2704217.
30
Dehghan H, Sarrafi Y, Salehi P, Ebrahimi SN. α-Glucosidase inhibitory and antioxidant activity of furanocoumarins from Heracleum persicum. Med Chem Res. 2017;26:849-55. doi: 10.1007/s00044-017-1796-y.
31
Abbas A, Grant PJ, Kearney MT. Role of IGF-1 in glucose regulation and cardiovascular disease. Expert Rev Cardiovasc Ther. 2008;6:1135-49. doi: 10.1586/14779072.6.8.1135. PubMed PMID: 18793116.
32
Wang X, Hu Z, Hu J, Du J, Mitch WE. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology. 2006;147:4160-8. doi: 10.1210/en.2006-0251. PubMed PMID: 16777975.
33
Sefi M, Fetoui H, Makni M, Zeghal N. Mitigating effects of antioxidant properties of Artemisia campestris leaf extract on hyperlipidemia, advanced glycation end products and oxidative stress in alloxan-induced diabetic rats. Food Chem Toxicol. 2010;48:1986-93. doi: 10.1016/j.fct.2010.05.005. PubMed PMID: 20457207.
34
Hajhashemi V, Dashti G, Saberi S, Malekjamshidi P. The effect of hydroalcoholic extract and essential oil of Heracleum persicum on lipid profile in cholesterol-fed rabbits. Avicenna J Phytomed. 2014;4:144-50. PubMed PMID: 25050312; PubMed Central PMCID: PMCPMC4104629.
35
Kopin L, Lowenstein C. Dyslipidemia. Ann Intern Med. 2017;167:ITC81-ITC96. doi: 10.7326/AITC201712050. PubMed PMID: 29204622.
36
Kurutas EB. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutr J. 2016;15:71. doi: 10.1186/s12937-016-0186-5. PubMed PMID: 27456681; PubMed Central PMCID: PMCPMC4960740.
37
Najeeb Q, Bhaskar N, Masood I, Wadhwa S, Kaur H, Ishaq S. Malondialdehyde (MDA) Superoxide dismutase (SOD) levels-distinguishing parameters betweenbenign malignant pleural effusions. Free Radicals and Antioxidants. 2012;2:8-11. doi: 10.5530/ax.2012.2.2.2.
38
ORIGINAL_ARTICLE
Formulation, Physiochemical, and Microbial Assay of Henna Oil Vaginal Suppository Formulated with Polyethylene Glycol Bases
Background: Persian Medicine is one of the oldest and richest complementary and alternative options in the field of medicine and has a comprehensive medical system. Henna oil is recommended in Persian Medicine for the treatment of numerous women’s diseases such as cervicitis. To date, henna has been used for many medical purposes, including astringent, bleeding, cardioinhibitory, hypotension, and relaxation. Accordingly, the present study aimed to provide the formulation of a henna-oil-based vaginal suppository and examine its physicochemical and antimicrobial properties. Methods: The present study was approved and performed in accordance with the regulations of Research Council, Kerman University of Medical Sciences, Kerman, Iran, in July 2016. Different percentages of henna oil, glycerin, and gelatin, as well as henna oil and polyethylene glycol 400 and 4000, were mixed to achieve a formulation with proper appearance features and, particularly, without any oil leakage from the suppository surface. Uniformity of weight, uniformity of content, disintegration time, and dissolution test of the suppositories were evaluated. The growth-inhibiting activity of the suppositories and aqueous extract of henna was evaluated against bacteria, including the Gram-positive bacterium Gardnerella vaginalis, Neisseria gonorrhoeae, and group B streptococcus. Results: The formulations had a smooth appearance without any cracks or fractures. Disintegration times for glycero-gelatin and polyethylene glycol suppositories were 60 and 10 min, respectively. 40% of the drug was released from polyethylene glycol suppositories after 60 min, but glycero-gelatin suppositories had no release after three hours. Minimum inhibitory concentration (MIC) of suppositories and aqueous extract were 0.4 mg/mL and 0.01 mg/mL, respectively. Conclusion: Polyethylene glycol suppositories had acceptable physicochemical properties, and the henna extract and suppositories inhibited the three studied pathogens.
https://ijms.sums.ac.ir/article_44965_a220696430d93d0cbdf36d4ffebadb81.pdf
2020-05-01
207
213
10.30476/ijms.2019.44965
Henna
Suppository
Uterine Cervicitis
Polyethylene glycols
Payam
Khazaeli
khazaeli.payam@gmail.com
1
Department of Pharmaceutics, School of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran
AUTHOR
Mitra
Mehrabani
mehrabani@hotmail.com
2
Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences, Kerman, Iran
AUTHOR
Ahmad
Mosadegh
mosadegh14@yahoo.com
3
Department of Microbiology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
AUTHOR
Soudabeh
Bios
so.bioos@gmail.com
4
Department of Iranian Traditional Medicine, School of Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Rahele
Zareshahi
rahele.zareshahi@gmail.com
5
Department of Traditional Medicine, School of Traditional Medicine, Kerman University of Medical Sciences, Kerman, Iran
LEAD_AUTHOR
Mohammad Hasan
Moshafi
moshafi14@yahoo.com
6
Department of Pharmacology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
AUTHOR
Pio I, Lavor AL, Damasceno CMD, Menezes PMN, Silva FS, Maia GLA. Traditional knowledge and uses of medicinal plants by the inhabitants of the islands of the Sao Francisco river, Brazil and preliminary analysis of Rhaphiodon echinus (Lamiaceae). Braz J Biol. 2019;79:87-99. doi: 10.1590/1519-6984.177447. PubMed PMID: 29694558.
1
Zafarghandi N, Jafari F, Moradi F, Alizadeh F, Karimi M, Alizadeh M. Frequency of Positive Symptoms of Dystemperament in Patients with Excess Uterine Hemorrhage from the Iranian Medicine Perspective. Iranian Journal of Obstetrics, Gynecology & Infertility. 2012;15:35.
2
Mokabberi Nezhad R, Zafarghandi N. Etiology and semiology of amenorrhea in the traditional Iranian medicine. J Islam Iran Trad Med. 2012;3:19-30.
3
Aghili Shirazi S. Makhzan-ol-Advieh [Storehouse of medicaments]. Tehran: Intisharat va Amoozesh Enghelab Islami Press; 1992.
4
Esteki R, Miraj S. The Abortificient Effects of Hydroalcoholic Extract of Lawsonia Inermis on BALB/c Mice. Electron Physician. 2016;8:2568-75. doi: 10.19082/2568. PubMed PMID: 27504174; PubMed Central PMCID: PMCPMC4965209.
5
Nesa L, Munira S, Mollika S, Islam M, Choin H, Chouduri AU, et al. Evaluation of analgesic, anti-inflammatory and CNS depressant activities of methanolic extract of Lawsonia inermis barks in mice. Avicenna J Phytomed. 2014;4:287-96. PubMed PMID: 25068143; PubMed Central PMCID: PMCPMC4110786.
6
Nayak BS, Isitor G, Davis EM, Pillai GK. The evidence based wound healing activity of Lawsonia inermis Linn. Phytother Res. 2007;21:827-31. doi: 10.1002/ptr.2181. PubMed PMID: 17533628.
7
Kermani MKK. Daghayegh-al-alaj, translation by Isa Zia Ebrahimi. Kerman: Saadat press; 1988.
8
Arzani MA. Tebbe Akbari. Qom: Ehiae Tebbe Tabiee; 2008.
9
Avicenna H. Al Qanoon Fi Al Teb. Tehran: Aligholikhan Press; 1880.
10
Rhazes (Razi MZ). Al-Hawi fi Tibb. Taaimi HK (ed). Beirut: Dar Ihyaa al-Turaath al-Arabi. 2002.
11
Baird D. Combined textbook of obstetrics and gynaecology for students and practitioners. California: Churchill Livingstone; 1969.
12
Aghili SMH. Gharabadin Kabir. 1st ed. Tehran: Iran University of Medical Sciences, Institute of History of Medicine Studies and Islamic Medicine; 2009. Persian.
13
Krowczynsky L. Suppositories in New Medicinal Practice. Poland; 1970.
14
Saghafi N, Karjalian M, Ghazanfarpour M, Khorsand I, Rakhshandeh H, Mirteimouri M, et al. The effect of a vaginal suppository formulation of dill (Anethum graveolens) in comparison to clotrimazole vaginal tablet on the treatment of vulvovaginal candidiasis. J Obstet Gynaecol. 2018;38:985-8. doi: 10.1080/01443615.2018.1432578. PubMed PMID: 29553834.
15
Nikakhtar Z, Hasanzadeh M, Hamedi SS, Najafi MN, Tavassoli AP, Feyzabadi Z, et al. The efficacy of vaginal suppository based on myrtle in patients with cervicovaginal human papillomavirus infection: A randomized, double-blind, placebo trial. Phytother Res. 2018;32:2002-8. doi: 10.1002/ptr.6131. PubMed PMID: 29943384.
16
Parmar V, Shivhare S. Formulation, Evaluation of Clotrimazole Vaginal Suppository. Research Journal of Pharmaceutical Dosage Forms and Technology. 2014;6:230.
17
Hashmi S, Begum W, Sultana A. Efficacy of Sphaeranthus indicus and cream of Lawsonia inermis in cervical erosion with cervicitis. Eur J Integr Med. 2011;3:e183-e8. doi: 10.1016/j.eujim.2011.08.002.
18
Talwar GP, Raghuvanshi P, Mishra R, Banerjee U, Rattan A, Whaley KJ, et al. Polyherbal formulations with wide spectrum antimicrobial activity against reproductive tract infections and sexually transmitted pathogens. Am J Reprod Immunol. 2000;43:144-51. PubMed PMID: 10735590.
19
Aulton ME, Taylor KM. Aulton’s pharmaceutics: the design and manufacture of medicines: Elsevier Health Sciences; 2017.
20
Jones BM, Bhattacharyya MN. In vitro susceptibility of Gardnerella vaginalis to high concentrations of sulfonamide compounds. Antimicrob Agents Chemother. 1981;19:666-7. PubMed PMID: 6972733; PubMed Central PMCID: PMCPMC181497.
21
Muhammad H, Muhammad S. The use of Lawsonia inermis Linn.(henna) in the management of burn wound infections. Afr J Biotechnol. 2005;4:934-7.
22
Kale VV, Trivedi RV, Wate SP, Bhusari KP. Development and evaluation of a suppository formulation containing Lactobacillus and its application in vaginal diseases. Ann N Y Acad Sci. 2005;1056:359-65. doi: 10.1196/annals.1352.017. PubMed PMID: 16387701.
23
ORIGINAL_ARTICLE
Genomic Detection of Mycobacterium Avium Subspecies Paratuberculosis in Blood Samples of Patients with Inflammatory Bowel Disease in Southern Iran
Background: Inflammatory bowel disease (IBD), of which Crohn’s disease (CD) and ulcerative colitis (UC) are the two main clinicopathological subtypes, is a group of digestive system diseases of unknown etiology. Risk factors for IBD are environmental factors, genetics, and immune system agents. Mycobacterium avium subspecies paratuberculosis (MAP) is one of the most important infectious factors and a suspected cause of IBD. The present study aimed to determine the prevalence of MAP in both IBD patients and non-IBD people as well as to investigate the relationship between the presence of this bacterium and IBD.Methods: A cross-sectional study was conducted during May-December 2017 among 146 IBD patients (32 with CD and 114 with UC) at the Motahari Clinic affiliated to Shiraz University of Medical Sciences, Shiraz, Iran. For comparison, the blood samples of 146 non-IBD volunteers (the control group) were tested for the presence of MAP using the polymerase chain reaction method (specific IS900 fragment). The data were analyzed using the SPSS software (version 19.0). The Kolmogorov-Smirnov test was used to evaluate the normal distribution of variables. The χ2 test was used to compare the qualitative variables between the groups.Results: MAP was present in 104 (71.2%) IBD patients out of which 24 (75%) had CD and 80 (70.2%) had UC. In the control group, MAP was present in 63 (43.2%) non-IBD volunteers. There was a significant association between the presence of IBD and MAP (p <0.001).Conclusion: A high prevalence of MAP was observed in the South of Iran. MAP DNA was detected in the blood samples of CD and UC patients as well as non-IBD volunteers. The high prevalence of MAP indicated a possible role of MAP in stimulating IBD.
https://ijms.sums.ac.ir/article_46531_1015dfae5a0b4ff3e4ae24b316e91435.pdf
2020-05-01
214
219
10.30476/ijms.2020.72403.0
Mycobacterium avium subspecies paratuberculosis
Crohn disease
Ulcerative colitis
Inflammatory bowel disease
Polymerase chain reaction
Saeid
Amirizadehfard
peimanb.2018@gmail.com
1
Department of Pathobiology, Shahrekord University, Shahrekord, Iran
AUTHOR
Mohammadreza
Mahzounieh
mahzouniehmohammadreza@gmail.com
2
Department of Pathobiology, Shahrekord University, Shahrekord, Iran
LEAD_AUTHOR
Alireza
Safarpour
safarpourar@gmail.com
3
Department of Internal Medicine, Gastroenterology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
AUTHOR
Maryam
Nejabat
maryam.nejabat@gmail.com
4
Department of Internal Medicine, Gastroenterology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
AUTHOR
Nazanin
Nazari
nazanin_nazari86@yahoo.co.uk
5
Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran
AUTHOR
Hosseini SV, Jafari P, Taghavi SA, Safarpour AR, Rezaianzadeh A, Moini M, et al. Fecal Calprotectin is an Accurate Tool and Correlated to Seo Index in Prediction of Relapse in Iranian Patients With Ulcerative Colitis. Iran Red Crescent Med J. 2015;17:e22796. doi: 10.5812/ircmj.22796. PubMed PMID: 25793117; PubMed Central PMCID: PMCPMC4353186.
1
Miranda-Bautista J, Padilla-Suarez C, Bouza E, Munoz P, Menchen L, Marin-Jimenez I. Listeria monocytogenes infection in inflammatory bowel disease patients: case series and review of the literature. Eur J Gastroenterol Hepatol. 2014;26:1247-52. doi: 10.1097/MEG.0000000000000188. PubMed PMID: 25171025.
2
Liverani E, Scaioli E, Cardamone C, Dal Monte P, Belluzzi A. Mycobacterium avium subspecies paratuberculosis in the etiology of Crohn’s disease, cause or epiphenomenon? World J Gastroenterol. 2014;20:13060-70. doi: 10.3748/wjg.v20.i36.13060. PubMed PMID: 25278700; PubMed Central PMCID: PMCPMC4177485.
3
Singh AV, Chauhan DS, Singh SV, Kumar V, Singh A, Yadav A, et al. Current status of Mycobacterium avium subspecies paratuberculosis infection in animals & humans in India: What needs to be done? Indian J Med Res. 2016;144:661-71. doi: 10.4103/ijmr.IJMR_1401_14. PubMed PMID: 28361818; PubMed Central PMCID: PMCPMC5393076.
4
Peterz M, Butot S, Jagadeesan B, Bakker D, Donaghy J. Thermal Inactivation of Mycobacterium avium subsp. paratuberculosis in Artificially Contaminated Milk by Direct Steam Injection. Appl Environ Microbiol. 2016;82:2800-8. doi: 10.1128/AEM.04042-15. PubMed PMID: 26944840; PubMed Central PMCID: PMCPMC4836428.
5
Martinek L, Kupka T, Simova J, Klvana P, Bojkova M, Uvirova M, et al. NOD2/CARD15 mutations and the risk of reoperation in patients with Crohns disease. Rozhl Chir. 2015;94:242-6. PubMed PMID: 26174343.
6
McNees AL, Markesich D, Zayyani NR, Graham DY. Mycobacterium paratuberculosis as a cause of Crohn’s disease. Expert Rev Gastroenterol Hepatol. 2015;9:1523-34. doi: 10.1586/17474124.2015.1093931. PubMed PMID: 26474349; PubMed Central PMCID: PMCPMC4894645.
7
Marks DJ, Harbord MW, MacAllister R, Rahman FZ, Young J, Al-Lazikani B, et al. Defective acute inflammation in Crohn’s disease: a clinical investigation. Lancet. 2006;367:668-78. doi: 10.1016/S0140-6736(06)68265-2. PubMed PMID: 16503465.
8
Qasem A, Safavikhasraghi M, Naser SA. A single capsule formulation of RHB-104 demonstrates higher anti-microbial growth potency for effective treatment of Crohn’s disease associated with Mycobacterium avium subspecies paratuberculosis. Gut Pathog. 2016;8:45. doi: 10.1186/s13099-016-0127-z. PubMed PMID: 27708718; PubMed Central PMCID: PMCPMC5041445.
9
Rath T, Roderfeld M, Blocher S, Rhode A, Basler T, Akineden O, et al. Presence of intestinal Mycobacterium avium subspecies paratuberculosis (MAP) DNA is not associated with altered MMP expression in ulcerative colitis. BMC Gastroenterol. 2011;11:34. doi: 10.1186/1471-230X-11-34. PubMed PMID: 21477272; PubMed Central PMCID: PMCPMC3080338.
10
Lee A, Griffiths TA, Parab RS, King RK, Dubinsky MC, Urbanski SJ, et al. Association of Mycobacterium avium subspecies paratuberculosis with Crohn Disease in pediatric patients. J Pediatr Gastroenterol Nutr. 2011;52:170-4. doi: 10.1097/MPG.0b013e3181ef37ba. PubMed PMID: 21206379.
11
Zamani S, Zali MR, Aghdaei HA, Sechi LA, Niegowska M, Caggiu E, et al. Mycobacterium avium subsp. paratuberculosis and associated risk factors for inflammatory bowel disease in Iranian patients. Gut Pathog. 2017;9:1. doi: 10.1186/s13099-016-0151-z. PubMed PMID: 28053669; PubMed Central PMCID: PMCPMC5209900.
12
Naser SA, Ghobrial G, Romero C, Valentine JF. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn’s disease. Lancet. 2004;364:1039-44. doi: 10.1016/S0140-6736(04)17058-X. PubMed PMID: 15380962.
13
Sibartie S, Scully P, Keohane J, O’Neill S, O’Mahony J, O’Hanlon D, et al. Mycobacterium avium subsp. Paratuberculosis (MAP) as a modifying factor in Crohn’s disease. Inflamm Bowel Dis. 2010;16:296-304. doi: 10.1002/ibd.21052. PubMed PMID: 19824071.
14
Nazareth N, Magro F, Machado E, Ribeiro TG, Martinho A, Rodrigues P, et al. Prevalence of Mycobacterium avium subsp. paratuberculosis and Escherichia coli in blood samples from patients with inflammatory bowel disease. Med Microbiol Immunol. 2015;204:681-92. doi: 10.1007/s00430-015-0420-3. PubMed PMID: 25994082.
15
Autschbach F, Eisold S, Hinz U, Zinser S, Linnebacher M, Giese T, et al. High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn’s disease. Gut. 2005;54:944-9. doi: 10.1136/gut.2004.045526. PubMed PMID: 15951539; PubMed Central PMCID: PMCPMC1774626.
16
Banche G, Allizond V, Sostegni R, Lavagna A, Bergallo M, Sidoti F, et al. Application of multiple laboratory tests for Mycobacterium avium ssp. paratuberculosis detection in Crohn’s disease patient specimens. New Microbiol. 2015;38:357-67. PubMed PMID: 26147146.
17
Collins MT, Lisby G, Moser C, Chicks D, Christensen S, Reichelderfer M, et al. Results of multiple diagnostic tests for Mycobacterium avium subsp. paratuberculosis in patients with inflammatory bowel disease and in controls. J Clin Microbiol. 2000;38:4373-81. PubMed PMID: 11101567; PubMed Central PMCID: PMCPMC87608.
18
ORIGINAL_ARTICLE
Primary Thoracic Wall Hydatid Cyst Extended to the Abdominal wall: A Case Report
Hydatid disease (HD) is an infectious disease caused by echinococcosis. Hydatid cyst (HC) most commonly invades the liver (60-70%) and the lungs (20-25%). However, other parts of the body and even unusual locations can be infected, mimicking a benign lesion that could be easily missed. Primary HC of the chest wall is extremely rare, even in countries where echinococcosis is endemic. We herein present a case of a 40-year-old man with a right-sided growing thoracic wall mass. The patient did not present the relevant history (living in rural areas or being in contact with farm animals) and the serological examination with the indirect hemagglutination test was negative. During surgery, a cystic mass between the eleventh and twelfth ribs was observed. The thoracic wall mass extended to the posterior abdominal wall and was entirely extrapulmonary and extraperitoneal. All cystic structures of the thoracic wall and intrathoracic region were removed, and the primary defect was reconstructed. In endemic areas such as Iran, HD should be considered in the differential diagnosis of mass lesions located in the chest wall or other parts of the body, even without the relevant history or serologic evidence.
https://ijms.sums.ac.ir/article_46532_28ac17d41ddfb2881b44d7898bf73af4.pdf
2020-05-01
220
223
10.30476/ijms.2019.82036.
Echinococcosis
Thoracic wall
Albendazole
Gholamali
Godazandeh
1
Department of Thoracic Surgery, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
AUTHOR
Farzad
Mokhtari-Esbuie
farzad.mokhtariesbuie@gmail.com
2
Department of General Surgery, School of Medicine, Iranshahr University of Medical Sciences, Iranshahr, Iran
LEAD_AUTHOR
Sara
Azooji
3
Department of Health Care, School of Medicine, Iranshahr University of Medical Sciences, Iranshahr, Iran
AUTHOR
HAgudelo Higuita NI, Brunetti E, McCloskey C. Cystic Echinococcosis. J Clin Microbiol. 2016;54:518-23. doi: 10.1128/JCM.02420-15. PubMed PMID: 26677245; PubMed Central PMCID: PMCPMC4767951.
1
Pedrosa I, Saiz A, Arrazola J, Ferreiros J, Pedrosa CS. Hydatid disease: radiologic and pathologic features and complications. Radiographics. 2000;20:795-817. doi: 10.1148/radiographics.20.3.g00ma06795. PubMed PMID: 10835129.
2
Eckert J, Gemmell M, Meslin F, Pawlowski Z. WHO/OIE manual on echinococcosis in humans and animals: a public health problem of global concern 2001. Geneva: World Organisation for Animal Health; p. 56-60.
3
Ertabaklar H, Dayanir Y, Ertug S. Research to investigate human cystic echinococcosis with ultrasound and serologic methods and educational studies in different provinces of Aydin/Turkey. Turkiye Parazitol Derg. 2012;36:142-6. doi: 10.5152/tpd.2012.34. PubMed PMID: 23169156.
4
Karaman U, Miman O, Kara M, Gicik Y, Aycan OM, Atambay M. Hydatid cyst prevalence in the region of Kars. Turkiye Parazitol Derg. 2005;29:238-40. PubMed PMID: 17124677.
5
Geramizadeh B. Unusual locations of the hydatid cyst: a review from iran. Iran J Med Sci. 2013;38:2-14. PubMed PMID: 23645952; PubMed Central PMCID: PMCPMC3642939.
6
Karapolat S, Dumlu T, Yildirim U, Karapolat B, Erbas M. Primary hydatid cyst of the chest wall. Lung. 2012;190:583-5. doi: 10.1007/s00408-011-9368-2. PubMed PMID: 22249910.
7
McManus DP, Zhang W, Li J, Bartley PB. Echinococcosis. Lancet. 2003;362:1295-304. doi: 10.1016/S0140-6736(03)14573-4. PubMed PMID: 14575976.
8
Shafiei R, Teshnizi SH, Kalantar K, Gholami M, Mirzaee G, Mirzaee F. The Seroprevalence of Human Cystic Echinococcosis in Iran: A Systematic Review and Meta-Analysis Study. J Parasitol Res. 2016;2016:1425147. doi: 10.1155/2016/1425147. PubMed PMID: 27830083; PubMed Central PMCID: PMCPMC5086504.
9
Argaw F, Abebe E, Tsehay A. Primary chest wall hydatid cyst, case report & review of literature. Annals of Clinical Case Reports. 2017;2:1245.
10
Thomopoulos T, Naiken S, Rubbia-Brandt L, Mentha G, Toso C. Management of a ruptured hydatid cyst involving the ribs: Dealing with a challenging case and review of the literature. Int J Surg Case Rep. 2012;3:253-6. doi: 10.1016/j.ijscr.2012.03.010. PubMed PMID: 22503916; PubMed Central PMCID: PMCPMC3356538.
11
Salih AM, Ahmed DM, Kakamad FH, Essa RA, Hunar AH, Ali HM. Primary chest wall Hydatid cyst: Review of literature with report of a new case. Int J Surg Case Rep. 2017;41:404-6. doi: 10.1016/j.ijscr.2017.10.051. PubMed PMID: 29546002; PubMed Central PMCID: PMCPMC5699876.
12
Salih AM, Kakamad FH, Hammood ZD, Yasin B, Ahmed DM. Abdominal wall Hydatid cyst: A review a literature with a case report. Int J Surg Case Rep. 2017;37:154-6. doi: 10.1016/j.ijscr.2017.06.022. PubMed PMID: 28683329; PubMed Central PMCID: PMCPMC5498266.
13
Ousadden A, Elbouhaddouti H, Ibnmajdoub KH, Mazaz K, Aittaleb K. A solitary primary subcutaneous hydatid cyst in the abdominal wall of a 70-year-old woman: a case report. J Med Case Rep. 2011;5:270. doi: 10.1186/1752-1947-5-270. PubMed PMID: 21722386; PubMed Central PMCID: PMCPMC3152916.
14
Dirican A, Unal B, Kayaalp C, Kirimlioglu V. Subcutaneous hydatid cysts occurring in the palm and the thigh: two case reports. J Med Case Rep. 2008;2:273. doi: 10.1186/1752-1947-2-273. PubMed PMID: 18700983; PubMed Central PMCID: PMCPMC2533018.
15
ORIGINAL_ARTICLE
Missing Pituitary Stalk: A Key to the Diagnosis
A 17-year-old female patient referred to the outpatient department for an evaluation of her short stature. In her physical examination, weight and height were less than 3 percentile for age. Delayed puberty was diagnosed as Tanner breast and pubic hair stage II. Lab data showed normal results for complete blood count, thyroid function test, fasting blood sugar, and serum electrolytes. The hormonal assay revealed low levels of basal luteinizing and follicle-stimulating hormones, as well as abnormal insulin-like growth factor 1 (IGF-1), and growth hormone stimulation tests. Wrist X-ray was performed, that confirmed significantly delayed bone age.
https://ijms.sums.ac.ir/article_46533_c0b0963c58c805e108e3e773699bd49d.pdf
2020-05-01
224
225
10.30476/ijms.2020.82182.1005
Pituitary Stalk
Pooya
Iranpour
pooya.iranpour@gmail.com
1
Medical Imaging Research Center, Department of Radiology, Shiraz University of Medical Sciences, Shiraz, Iran
LEAD_AUTHOR
Sara
Haseli
sarahaseli@gmail.com
2
Medical Imaging Research Center, Department of Radiology, Shiraz University of Medical Sciences, Shiraz, Iran
AUTHOR
Bar C, Zadro C, Diene G, Oliver I, Pienkowski C, Jouret B, et al. Pituitary Stalk Interruption Syndrome from Infancy to Adulthood: Clinical, Hormonal, and Radiological Assessment According to the Initial Presentation. PLoS One. 2015;10:e0142354. doi: 10.1371/journal.pone.0142354. PubMed PMID: 26562670; PubMed Central PMCID: PMCPMC4643020.
1
Wang CZ, Guo LL, Han BY, Su X, Guo QH, Mu YM. Pituitary Stalk Interruption Syndrome: From Clinical Findings to Pathogenesis. J Neuroendocrinol. 2017;29. doi: 10.1111/jne.12451. PubMed PMID: 27917547.
2
Wang CZ, Guo LL, Han BY, Wang AP, Liu HY, Su X, et al. Growth Hormone Therapy Benefits Pituitary Stalk Interruption Syndrome Patients with Short Stature: A Retrospective Study of 75 Han Chinese. Int J Endocrinol. 2016;2016:1896285. doi: 10.1155/2016/1896285. PubMed PMID: 27190512; PubMed Central PMCID: PMCPMC4846761.
3